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Abstract 
 
Drug toxicity testing is a necessary part of the drug development process and it is required by the 
regulatory authorities. Genotoxicity, the ability of drugs to cause DNA damage, is tested by both in 
vivo and in vitro tests. In vitro DNA damage assays have high sensitivity but low specificity and 
hence they cause misleading positive results, which leads to unnecessary animal testing. Animal 
testing is expensive and causes ethical issues. 
 
Drugs that cause dysfunction in mitochondria are called mitochondrial toxins. Since the majority of 
the ATP is produced in mitochondria, mitochondrial toxins may cause insufficient energy production 
in mammalian cells. Since many processes in the cell, such as the cell cycle regulation, DNA 
damage repair and cytoskeleton dynamics, are energy dependent, the ATP depletion could possibly 
lead to indirect DNA damage response. The aim of this study was to investigate if the ATP depletion 
caused by the mitochondrial toxins induces the DNA damage indirectly and hence lead to 
misleading positive results in genotoxic assays. The focus was on examining whether the ATP 
depletion would cause DNA damage via changed dynamics of cytoskeleton.  
 
The study was conducted with High-content analysis (HCA). HepG2/C3A cells were treated with 16 
compounds, 15 mitochondrial toxins and one genotoxic agent, paclitaxel. The cells were 
immunolabeled to detect tubulin and actin fibers, nuclei, DNA double strand breaks and mitotic cells. 
Excluding metformin, all of the mitochondrial toxins did increase the DNA damage response 
significantly (p<0.05) in HepG2/C3A cells. Most of these compounds seemed to increase the DNA 
damage due to the cell death. However, most of the compounds that interfere with ATP production 
via uncoupling, increased DNA damage response without the cell death. Paclitaxel was the only 
compound that increased both the DNA double strand break marker and the mitotic marker 
simultaneously. Since the DNA damage marker and mitosis marker had a negative correlation it can 
be concluded that energy depletion did not cause dysfunction in the cell cycle regulation. Paclitaxel 
and most of the mitochondrial toxins seemed to affect the tubulin and actin dynamics. There 
appeared to be association between DNA damage and changed cytoskeleton dynamics but the 
causality of the two was not verified and requires further investigation. Whether the responses were 
due to the ATP depletion or general cytotoxicity of the mitochondrial toxins, was not confirmed in 
this study. 
 
Keywords Mitochondrial toxicity, ATP depletion, DNA damage, cytoskeleton dynamics, 
                  High-content analysis (HCA).  
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Tiivistelmä 
 
Lääkkeiden toksisuuden testaaminen on oleellinen osa lääkekehityskaarta ja 
lääkevalvontaviranomaiset velvoittavat sitä myyntilupaa hakevilta valmisteilta. Lääkkeet, jotka 
aiheuttavat vaurioita suoraan DNA:han, ovat genotoksisia. Genotoksisuutta tutkitaan niin in vivo- 
kuin in vitro -menetelmillä. DNA-vaurioiden tutkimista varten kehitellyt in vitro –testit ovat herkkiä, 
mutta epäspesifisiä, mistä johtuen ne antavat harhaanjohtavia positiivisia tuloksia. Tämä johtaa 
turhiin eläinkokeisiin, jotka ovat kalliita ja herättävät eettisiä kysymyksiä.      
 
Mitokondrioihin vaikuttavat toksiinit aiheuttavat mitokondrioiden vajaatoimintaa ja koska suurin osa 
nisäkässolujen ATP-tuotannosta tapahtuu niissä, voi solujen altistuminen näille toksiineille johtaa 
riittämättömään energiatuotantoon. Monet solussa tapahtuvat prosessit, kuten solusyklin sääntely, 
DNA:n korjausmekanismit ja solutukirankadynamiikka, ovat energiariippuvaisia. Tämän 
tutkimuksen tarkoituksena oli selvittää, voiko mitokondriotoksisuudesta johtuva energiavaje johtaa 
epäsuorasti DNA-vaurioihin ja aiheuttaa siten harhaanjohtavia positiivisia tuloksia 
genotoksisuustesteissä. Työssä keskityttiin tutkimaan, aiheuttiko ATP:n puutos DNA-vaurioita 
nimenomaan muuttuneen solutukirankadynamiikan vuoksi.   
 
Tämä tutkimus suoritettiin High-content analysis (HCA) –metodilla. HepG2/C3A-solut käsiteltiin 
16:lla aineella, joista 15 oli mitokondriotoksisia ja yksi, paklitakseli, genotoksinen. Soluille suoritettiin 
vasta-ainevärjäys, jolla paikallistettiin solujen tumat, mikrotubulukset, aktiinisäikeet, DNA-katkokset 
ja mitoottiset solut. Metformiinia lukuun ottamatta kaikki mitokondriotoksiinit lisäsivät DNA-katkosten 
määrää merkitsevästi (p<0.05) HepG2/C3A-soluilla. Suurella osalla näistä toksiineista DNA-
katkosten lisääntyminen näytti johtuvan solukuolemasta. Aineet, jotka aiheuttivat ATP:n puutosta 
irtikytkennästä johtuen, lisäsivät DNA-katkosten määrää, vaikka solukuolemien määrä ei 
lisääntynyt. Paklitakseli oli ainoa aine, joka lisäsi sekä DNA-katkosten että mitoottisten solujen 
osuutta samanaikaisesti. Muilla aineilla DNA-katkosten ja mitoottisten solujen esiintyvyydellä oli 
negatiivinen assosiaatio. Tästä voidaan päätellä, että ATP:n puutos ei aiheuttanut vajaatoimintaa 
solusyklin sääntelymekanismeissa. Paklitakseli ja suurin osa mitokondriotoksiineista näyttivät 
vaikuttavan tubuliinin ja aktiinin dynamiikkaan. DNA-katkoksilla ja solutukirankadynamiikan 
muutoksilla näytti olevan yhteys, mutta kausaliteettia näiden välillä ei tässä tutkimuksessa pystytty 
varmistamaan ja asia vaatii siten jatkotutkimuksia. Tässä tutkimuksessa ei varmistunut, johtuivatko 
mitokondriotoksiineiden aiheuttamat muutokset solutukirankadynamiikassa ja DNA-katkosten 
määrässä ATP;n puutoksesta vai kyseisten aineiden yleisestä solutoksisuudesta.  
 
Avainsanat  Mitokondriotoksisuus, ATP:n puutos, DNA-vaurio, solutukirankadynamiikka.  
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I INTRODUCTION 
 
Toxicology screening is an important part of the drug development when performing 
the risk-benefit assessment (Bluemel, 2012). Screening can be done in vivo by animal 
testing and in vitro by using cell lines or primary cells (Parasuraman, 2011). 
Investigation of drug toxicology is required by the regulatory authorities and there are 
generally accepted guidelines available for toxicology testing (Whitebread et al., 
2005). Approximately 30% of drug candidates never reach the market due to their 
toxicity (Guengerich, 2011; Whitebread et al., 2005). Drug toxicity is also a significant 
reason for drug withdrawal and addition of black box warnings after the approval 
(Abraham et al., 2008). Failing of the drug candidate in the late stage of drug 
development is highly expensive and therefore optimization of early-stage preclinical 
toxicology studies is important (Verbist et al., 2015). 
 
All drugs are toxic if the dose is high enough and thus drug toxicity that leads to 
candidate failing refers to toxic effects that are expressed at therapeutic doses 
(Guengerich, 2011). The mechanisms of different toxins vary greatly. Cytotoxicity 
refers to toxicity that reduces the viability of the cells by decreasing the proliferation 
or leading to cell death (Nicolette, 2012). Mitochondrial toxicity is one form of 
cytotoxicity and it refers to toxic effects that pharmaceuticals may have on 
mitochondria (Meyer et al., 2018). Since mitochondria produce most of the energy 
that is used by the cell, mitochondrial toxins may cause energy depletion in the cell 
and this may lead to apoptosis (Wallace & Starkov, 2000).  
 
Genotoxicity refers to ability of compounds to cause DNA damage and it may lead to 
inheritable defects or cancer formation (Nicolette, 2012). The International Council for 
Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) 
has set a guideline for adequate genotoxicity testing. According to this guideline, all 
pharmaceuticals need to go through a test for gene mutation in bacteria (AMES test) 
and either two separate in vivo genotoxicity tests or one in vivo and one in vitro 
genotoxicity test. (ICHS2(R1), 2011) The Organization for Economic Co-operation 
and Development (OECD) has set more detailed guideline for each in vitro and in vivo 
test (OECD, 2015).   
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The currently used in vitro tests for genotoxicity have high sensitivity but low 
specificity, which leads to high rate of false positives (Corvi & Madia, 2017). The false 
and misleading positives in in vitro tests lead to follow-up in vivo tests and to 
unnecessary animal testing (Kirkland et al., 2007). This is problematic due to the 
ethical issues and high costs (Benigni & Bossa, 2011). The ways to decrease the false 
positives in in vitro tests have been investigated (Corvi & Madia, 2017). It seems that 
the rate of misleading positives can be reduced e.g. by adjusting the top concentration 
of the compound and by choosing a suitable cell type (Fowler et al., 2012a; Fowler et 
al., 2012b; Parry et al., 2010). 
 
The aim of this research was to investigate if energy depletion caused by 
mitochondrial toxicity may be responsible for the misleading positives in DNA damage 
assays. If the energy production is insufficient, the cell may not be capable of 
performing all its functions properly and this might lead indirectly to DNA damage. An 
indirect induction of DNA damage is not considered as an indication of genotoxicity 
and hence this type of actual but indirect response of DNA damage is not considered 
straightforwardly as “positive”. The focus in this research was on examining the impact 
of energy deprivation on cytoskeletal dynamics during mitosis, and estimating 
whether it might mediate the genotoxic effect. 
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II LITERATURE REVIEW 
 
1 Mitochondrial toxicity 
 
1.1 Structure of mitochondria 
 
Mitochondria are cytosolic organelles with a diameter of 0.5–1 µm (Alberts et al., 
2015d, p. 755). They are found in every human cell, apart from mature erythrocytes. 
Their number per cell depends on the energy need of the cell type. Metabolically 
active cells, such as the ones found in liver and heart, have high number of 
mitochondria. (Neustadt & Pieczenik, 2008) The shape of the mitochondria may be 
constantly changing and varies depending on the tissue (Alberts et al., 2015d, p. 755). 
Mitochondria also interact with other cellular components, mainly with cytoskeleton 
and endoplasmic reticulum (ER) (Frey & Mannella, 2000). They consist of an outer 
and inner membrane. Both of these membranes consist of phospholipid bilayer and 
membrane proteins. (Krauss, 2001) The membranes confine the two mitochondrial 
compartments: intermembrane space that lies between the outer and inner 
membranes and the matrix that is located inside the inner membrane. (Harris & 
Thompson, 2000) The structure of a mitochondrion is illustrated in figure 1. 
 
The outer membrane of the mitochondria is permeable to molecules smaller than 
5000 Daltons. The high permeability is enabled by porins, also known as voltage-
dependent anion channels (VDACs). VDACs are the most abundant proteins in the 
outer membrane. (Harris & Thompson, 2000) The protein-to-lipid ratio for the outer 
mitochondrial membrane is about 50:50 (Krauss, 2001). Due to the high permeability, 
the pH and ionic composition of the intermembrane space is equivalent to cytosol 
(Alberts et al., 2015d, p. 757). However, the outer membrane is impermeable to 
apoptosis promoting proteins, which are present in the intermembrane space. This 
impermeability enables the regulation of apoptosis. (Harris & Thompson, 2000) 
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The transportation across the inner membrane is more tightly regulated than transport 
through the outer membrane (Harris & Thompson, 2000). The inner membrane is 
folded into cristae and has a large surface area. It contains several transport proteins, 
including electron transport chain (ETC) and ATP synthase, and the protein-to-lipid 
ratio is approximately 80:20. (Amacher, 2005; Krauss, 2001) The inner membrane is 
impermeable and small molecules can pass it only with the aid of membrane transport 
proteins. The content of the matrix can therefore be regulated and it enables the 
formation of electron gradient across the inner membrane. (Wallace & Starkov, 2000) 
The matrix contains e.g. several enzymes and mitochondrial DNA, RNA and 
ribosomes (Alberts et al., 2015d, p. 759; Frey & Mannella, 2000). Some of the inner 
membrane proteins are produced by the mitochondria themselves in the matrix (Frey 
& Mannella, 2000).   
 
 
 
Figure 1. The structure of the mitochondria. Mitochondria consist of an outer and inner membrane, 
intermembrane space and matrix. Inner membrane is folded into cristae. Mitochondria contain their own 
DNA (mtDNA) and ribosomes and granules participate the synthesis of mitochondrial proteins. 
Mitochondria produce ATP by ATP synthase that is located in the inner membrane. (Frey & Mannella, 
2000) 
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1.2 Energy production in eukaryotic cell 
 
In order to function, the cells require energy. The energy is needed e.g. for growth, 
division, migration and maintenance of the cell structure. The cells need an external 
energy source that they can utilize to produce adenosine triphosphate (ATP). (Haug 
et al., 2009, p. 46) ATP is the main chemical energy currency of the cell (Alberts et 
al., 2015d, p. 754). The cells produce ATP via glycolysis or oxidative phosphorylation. 
A small amount of ATP is also produced in citric acid cycle.  
 
1.2.1 Glycolysis 
 
Glycolysis is a process where ATP is produced without the presence of oxygen. It 
occurs in the cytosol of the cell. In the glycolysis, a glucose molecule is degraded into 
two pyruvate molecules. This process consumes two and produces four molecules of 
ATP. Hence, the yield is two ATP molecules per one glucose molecule. (Alberts et al., 
2015a, p. 74) Glycolysis consists of multiple steps that are shown in figure 2. ATP is 
produced in two different stages. The first ATP molecules are generated when 
phosphoglycerate kinase catalyses reaction where 1,3-bisphosphoglycerate donates 
one phosphoryl group to adenosine diphosphate (ADP). As a product, ATP is 
produced. The second stage where ATP is generated is the final stage of glycolysis 
where pyruvate is being produced. Pyruvate kinase catalyzes reaction where a 
phosphate group is transferred from phosphoenolpyruvate to ADP, generating ATP. 
During glycolysis, also two molecules of coenzyme nicotinamide adenine dinucleotide 
(NADH) are produced. (Berg et al., 2002c)  
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1.2.2 Oxidative Phosphorylation 
 
Over 90% of the ATP is produced in the mitochondria via oxidative phosphorylation 
(Amacher, 2005; Neustadt & Pieczenik, 2008). This process is efficient and produces 
more ATP than glycolysis (Zheng, 2012). Oxidative phosphorylation takes place in 
the inner mitochondrial membrane and consists of two consecutive events. The first 
event is an electron flow through the electron transport chain that generates a proton 
gradient across the inner membrane. This is followed by the second event where ATP 
synthase utilizes the proton gradient to produce ATP from ADP. (Saraste, 1999)  
 
The electrons for the ETC are gained from the coenzymes NADH and flavin adenine 
dinucleotide (FADH2) (Neustadt & Pieczenik, 2008). As mentioned earlier, NADH is 
Figure 2. Glycolysis. In glycolysis, glucose is degraded via several steps into two pyruvate molecules. 
During the first steps of glycolysis, two ATP molecules are consumed and at steps 7 and 10, four ATP 
molecules are produced. The total yield in glycolysis is two molecules of ATP per one glucose molecule. 
In addition, two molecules of NADH are produced during glycolysis. (Adapted from Alberts et al., 2015a, 
p. 75.) 
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produced in glycolysis in the cytosol (Berg et al., 2002c). NADH is transported into 
mitochondria through the malate-aspartate shuttle (Eto et al., 1999). In addition, 
NADH is formed in the citric acid cycle where also the FADH2 is produced. Citric acid 
cycle takes place in the mitochondrial matrix and it utilizes acetyl Coenzyme A (acetyl 
CoA) as its fuel to produce NADH and FADH2. (Neustadt & Pieczenik, 2008) Acetyl 
CoA is produced either by β-oxidation of fatty acids or by oxidative decarboxylation of 
the pyruvate generated from glycolysis (Berg et al., 2002a; Neustadt & Pieczenik, 
2008). One round of citric acid cycle produces three molecules of NADH and one 
molecule of FADH2. In addition, one molecule of ATP is produced. (Modica-
Napolitano et al., 2007) The overview of energy production in mitochondria is 
described in figure 3.  
 
 
 
Figure 3. Overview on energy production in mitochondria. Fatty acids and pyruvate enter mitochondria 
where they are transformed into acetyl CoA. Acetyl CoA is fuel for citric acid cycle that produces NADH. 
NADH donates two electrons that flow through ETC producing proton gradient across the inner 
mitochondrial membrane. ATP synthase utilizes proton gradient to produce ATP from ADP. ATP is 
transported from the mitochondria to cytosol by ADP/ATP carrier proteins. (Alberts et al., 2015d, p. 759) 
  
 
8 
 
The electron transport chain includes four complexes, each of which consist of several 
proteins (Brinkman et al., 1998). These complexes are NADH:ubiquinone 
oxidoreductase (complex I), succinate:ubiquinone reductase (complex II), cytochrome 
bc1 (complex III) and cytochrome c oxidase (complex IV). The complexes transport 
the electrons from NADH and FADH2 to oxygen and H2O is formed. (Huttemann et 
al., 2007) These reactions are highly energy-yielding and the energy is released 
gradually in each step of the transportation chain (Lodish et al., 2000). The released 
energy is used for pumping protons from matrix to intermembrane space and this is 
done by complexes I, III and IV. The evolved proton gradient is utilized by the ATP 
synthase (complex V). (Brand, 2000) The ETC and ATP synthase are shown in figure 
4. 
 
 
 
Each complex in ETC has their own specific function. Complex I is a L-shaped 
structure consisting of over 40 different subunits (Guenebaut et al., 1998; Huttemann 
et al., 2007; Sled et al., 1994). It is the largest and most complicated of the ETC 
complexes (Estornell, 2000). NADH enters ETC in complex I and it is oxidized to NAD+ 
by cofactor flavin mononucleotide (FMN). Two electrons are released and they flow 
through eight iron-sulfur clusters to reduce ubiquinone (Q) to ubiquinol (QH2). (Hirst, 
2009) QH2 is transported to the complex III (MacAskill & Kittler, 2010). Complex I 
Figure 4. Complexes I-IV of ETC and ATP synthase (complex V). Complex I accepts electrons from 
NADH and complex II from FADH2 that is produced when succinate oxidizes to fumarate. Electrons flow 
via ubiquinone (Q) to complex III and via cytochrome c to complex IV. At complex IV electrons reduce 
oxygen to water. Complexes I, III and IV pump protons from mitochondrial matrix to intermembrane 
space and ATP synthase utilizes formed proton gradient to produce ATP from ADP.  (Adapted from 
Osellame et al., 2012) 
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pumps four protons per NADH from mitochondrial matrix to the intermembrane space 
(Hirst, 2009).    
 
Complex II is a part of citric acid cycle. One of its four subunits is responsible for the 
generation of FADH2 that is produced when succinate is oxidized to fumarate. 
Complex II also feeds electrons from FADH2 into the ETC. (Modica-Napolitano et al., 
2007) Hence, FADH2 never leaves the complex but it is oxidized to FAD and two 
electrons are released and transported through three iron-sulfur clusters (Lodish et 
al., 2000; Tomitsuka et al., 2003). The electrons flow to ubiquinone and reduce it to 
ubiquinol which is transported to complex III (Lodish et al., 2000). Complex II does 
not transport protons across the inner membrane (Huttemann et al., 2007).    
 
Complex III has 11 subunits and it catalyzes the reaction where electrons from QH2 
are transferred to cytochrome c. Cytochrome c is an electron carrier that is located on 
the outer surface of the inner membrane and it transfers one electron at a time from 
complex III to complex IV. (Modica-Napolitano et al., 2007) Complex III itself contains 
three electron transfer proteins, cytochrome c1, cytochrome b and an iron-sulfur 
protein (Trumpower, 1990). Complex III transfers electrons and pumps protons to the 
intermembrane space by a mechanism called the protonmotive Q cycle (Grossman 
et al., 2004). Complex III pumps four protons to the intermembrane space. 
(Trumpower, 1990) 
 
Complex IV is the final complex in the ETC and it consists of 13 subunits (Grossman 
et al., 2004). In complex IV, cytochrome c is oxidized and the electron flows via copper 
ions and cytochrome a and a3 to O2, which is the final electron acceptor (Saraste, 
1999). One electron pair reduces only one oxygen atom and one water molecule is 
produced. Therefore, four electrons are needed to reduce one O2 molecule. Complex 
IV pumps two protons to the intermembrane space per one electron pair. (Lodish et 
al., 2000) 
 
The final step in oxidative phosphorylation is the production of ATP by the ATP 
synthase. ATP synthase, or F1F0ATPase, is also called complex V even though it is 
not part of the ETC. It is functionally reversible enzyme, meaning that it can both 
produce and hydrolyze ATP. ATP synthase consists of two functional domains: F1 and 
F0. F1 is located in mitochondrial matrix and has five different subunits: three copies 
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of α and β and one copy of γ, δ and ε. (Saraste, 1999) F1 domain is responsible for 
the production of ATP from ADP and inorganic phosphate Pi. F0 is bound to the inner 
mitochondrial membrane and includes ten different subunits: a, b, c, d, e, f, g, A6L, F6 
and OSCP. Subunit c is thought to have eight copies that form a ring-shaped structure 
but other subunits have only one copy of each. (Jonckheere et al., 2012) F0 domain 
forms a proton channel across the inner membrane (Saraste, 1999). The subunits of 
ATP synthase are shown in figure 5.  
 
 
 
The proton gradient produced by the ETC drives protons to flow from mitochondrial 
intermembrane space to the matrix. The protons flow across the inner membrane via 
the subunits a and c. This proton flow releases energy and causes rotation of the c 
subunit ring and subunits ε, δ and γ. (Jonckheere et al., 2012) The rotation causes 
conformational changes in the β subunits which are the catalytic sites for ATP 
production. The binding sites for ADP, Pi and ATP are located in the interface of α 
and β subunit. β subunits have three different conformations: open (O), loose (L) and 
tight (T). In open conformation ADP and Pi enters the binding site and their binding 
affinity increases in the L state. In T state ADP and Pi approach each other and form 
Figure 5. Human mitochondrial ATP synthase and its subunits. F1 domain is located in the 
mitochondrial matrix and consists of α, β, γ, δ and ε subunits. F0 domain is in the inner 
mitochondrial membrane and includes a, b, c, d, e, f, g, A6L, F6 and OSCP subunits. (Jonckheere 
et al. 2012) 
  
 
11 
 
spontaneously ADP. ADP is then released to the mitochondrial matrix in the O state. 
(Faccenda & Campanella, 2012) 
 
In oxidative phosphorylation 2.5 ATP molecules are produced per electron pair 
donated by NADH and 1.5 ATP molecules per electron pair from FADH2  (Alberts et 
al., 2015d, p. 775). FADH2 produces less ATP since complex II doesn’t participate in 
the formation of the proton gradient across the inner membrane (Huttemann et al., 
2007). The produced ATP can be transported from the matrix by ADP/ATP carrier 
proteins that are located in the inner membrane. They release ATP via intermembrane 
space to the cytosol and ATP can be used for energy-requiring processes everywhere 
in the cell. (Alberts et al., 2015d, pp. 779-782)    
 
1.3 Targets of mitochondrial toxicity 
 
As mentioned in the chapter 2.1 the number of mitochondria varies within different 
cell types. The cells that have highest amount of mitochondria are also more easily 
affected by diverse effects caused by the mitochondrial toxins. (Amacher, 2005) Also 
tissues that are exposed to higher concentrations of pharmaceuticals, such as the 
liver, are more easily affected (Dykens & Will, 2007). There are several different 
mechanisms for mitochondrial toxicity that can cause harm for the host cell. 
Mitochondrial toxins may induce apoptosis in the cell and increase the production of 
DNA damaging reactive oxygen species (ROS). (Amacher, 2005) Since mitochondria 
are responsible for the energy production in the cell, one major consequence of 
mitochondrial toxicity is insufficient energy production (Wallace & Starkov, 2000). 
Even though glycolysis can partly compensate the energy loss caused by 
mitochondrial dysfunction, oxidative phosphorylation is often needed to cover the 
energy requirements of the functioning cell (Salazar-Roa & Malumbres, 2017). Energy 
deprivation may cause dysfunction in ATP-dependent processes, such as cell cycle 
regulation and cell division (Peyressatre et al., 2015; Salazar-Roa & Malumbres, 
2017). 
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1.3.1 Inhibitors of ETC and ATP synthase 
 
Mitochondrial toxicity can be caused by the inhibition of the electron flow across the 
ETC (Amacher, 2005). When one or more complexes of the ETC are inhibited, it 
affects the generation of the proton gradient across the inner membrane and 
interferes with the production of ATP.  
 
Complex I is very vulnerable to mitochondrial toxins and there are more than 60 
different types of compounds that inhibit its activity (Amacher, 2005; Wallace & 
Starkov, 2000). Due to its complexity, there has been a lot of debate about the 
mechanisms and binding sites of complex I inhibitors (Degli Esposti, 1998; Estornell, 
2000; Murai & Miyoshi, 2016). Even though the binding sites and affinities of different 
inhibitors may vary, it seems that most of the inhibitors affect in the ubiquinone binding 
pocket. Binding to this pocket disturbs the electron flow from iron-sulfur clusters to the 
ubiquinone. (Estornell, 2000)   
 
Complex II inhibition has been described much less than inhibition of other ETC 
complexes (Miyadera et al., 2003). There are some inhibitors that seem to interfere 
with the binding of electrons to the ubiquinone and inhibit the reduction of ubiquinone 
to ubiquinol (Hagerhall, 1997). Complex III inhibitors can be categorized based on 
their binding sites in the Q cycle (Esser et al., 2004). Regardless of the binding site, 
the inhibitors block the electron flow in the Q cycle and interfere with the generation 
of proton gradient (Ma et al., 2011). 
 
The inhibition of complex IV may occur via several different mechanisms (Wallace & 
Starkov, 2000). Some toxins prevent the proper binding of cytochrome c by binding 
close to its oxidation site and thus blocking the electron flow. The electron flow can 
also be inhibited inside the complex IV by the reaction with cytochrome a3 or copper 
ions. (Sarti et al., 2003; Wallace & Starkov, 2000) 
 
Toxins can inhibit ATP synthase by binding to its Fo or F1 domain. Depending on the 
compound, the binding site may vary. (Zheng & Ramirez, 2000) Binding to Fo domain 
interferes with the proton flow across the ATP synthase and hence blocks the 
production of ATP (Devenish et al., 2000; Symersky et al., 2012). Binding to F1 domain 
prevents the production of ATP from ADP and Pi. F1 inhibitors seem to disturb the 
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conformational changes of β subunits that are critical for ATP synthase to function. 
(Abrahams et al., 1996) 
 
1.3.2 Uncouplers of oxidative phosphorylation 
 
The ATP production by oxidative phosphorylation can also be inhibited via 
uncoupling. Uncoupling refers to a mechanism where after the production of proton 
gradient the protons do not pass across the ATP synthase when flowing back to the 
mitochondrial matrix. Instead, they flow across the inner membrane directly and 
proton gradient collapses. Instead of ATP only heat is produced. (Amacher, 2005) 
 
Most of the uncouplers are lipophilic weak organic acids or weak bases (Kadenbach, 
2003; Krahenbuhl, 2001). These uncouplers are able to cross the inner membrane 
both in deprotonated and protonated forms. In the intermembrane space they bind 
protons and transport them across the membrane to the matrix. (Kadenbach, 2003) 
In the matrix uncouplers release the proton and are ready to go back to 
intermembrane space and bind another proton. This cycle collapses the proton 
gradient. (Wallace & Starkov, 2000)  
 
1.3.3 Other possible targets of mitochondrial toxicity 
 
Toxins that induce the mitochondrial permeability transition (MPT) or inhibit fatty acid 
β-oxidation or mitochondrial DNA (mtDNA) synthesis can also interfere with the 
energy production of mitochondria (Amacher, 2005).  
 
As mentioned in the chapter 2.2.2. β-oxidation is an essential process to generate 
NADH and FADH2. The prevention of the NADH and FADH2 production by β-oxidation 
results in the dysfunction of ETC and decreases the ATP formation in the cell. 
(Fromenty & Pessayre, 1997) Except for complex II, all the complexes in ETC and 
ATP synthase are partly encoded by mtDNA. Toxins that inhibit the mtDNA synthesis 
affect also the formation and function of the complexes of ETC. (Brinkman et al., 1998)  
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Some compounds may induce the mitochondrial permeability transition in the cell. 
MPT is induced when mitochondrial permeability transition pores (MPTPs) are 
opened. The structure of the MPTPs are not completely understood but they seem to 
be located at the contact sites of outer and inner mitochondrial membrane. When the 
pores are opened, molecules under 1500 Daltons can pass freely from the 
mitochondrial matrix to the cytosol of the cell. This disrupts the proton gradient and 
prevents the ATP production. (Halestrap, 2009) ATP depletion is not the only 
consequence of the MPT which also causes e.g. swelling of the matrix and imbalance 
of the ion gradients across the inner membrane. Depending on the duration and extent 
of MPTP opening, the cell may survive but often MPT leads to apoptosis or necrosis. 
(Honda & Ping, 2006; Labbe et al., 2008)  
 
2.  Cell cycle 
 
2.1 Overview of the cell cycle 
 
Cells reproduce by dividing. The content of the cell is first duplicated and the mother 
cell divides into two daughter cells. This process is continual and is known as a cell 
cycle. Cell cycle is a highly conserved process even though its details may vary 
depending on the cell type. (Alberts et al., 2015b, p. 963) Cell cycle consists of multiple 
energy-dependent processes as will be explained in chapter 2.3 (Salazar-Roa & 
Malumbres, 2017).  
 
The cell cycle can be seen in figure 6. It consists of four main stages: G1, S, G2 and 
M phases (Vermeulen et al., 2003). M phase consists of mitosis and cytokinesis 
(Cooper, 2000). G1, S and G2 phases form together the interphase. The DNA 
replication occurs in the S phase and the division of the cell takes place in the M 
phase (Vermeulen et al., 2003). G1 and G2 phases are so called gap phases. Gap 
phases give the cell time to grow and to verify that it is prepared for the next phase. 
However, cell growth occurs throughout the interphase. (Alberts et al., 2015b, pp. 
964-965) Mitochondria increase their mass in the G1 phase and are segregated in the 
G2 phase (Lee et al., 2007; Salazar-Roa & Malumbres, 2017).  
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Cells may reversibly exit the cell cycle into a resting, G0, phase, where proliferating 
and growing stops (Oki et al., 2014; Vermeulen et al., 2003). Exit to the resting phase 
occurs when the extracellular conditions become unfavourable, e.g. there is depletion 
of nutrients or changes in cell adhesion (Oki et al., 2014). The duration of the G0 phase 
varies greatly and it may take even years before the cell re-enters the cell cycle. Some 
cells remain in the resting phase permanently. (Alberts et al. 2015, pp. 965) Terminally 
differentiated cells that do not divide are irreversibly arrested at G0 phase (Yao, 2014).  
 
2.1.1 Cytoskeleton 
 
Cytoskeleton has an important role in the cell cycle and especially in the mitosis. The 
cell also maintains its shape, structures its inner components and migrates by its 
cytoskeleton. Cytoskeleton is composed of three different types of filaments: 
microfilaments, microtubules and intermediate filaments. Since cytoskeleton is 
responsible for the mechanical functions and spatial organization, it needs to be able 
Figure 6. The stages of the cell cycle. Interphase consists of G1, S and G2 phases. During interphase the 
cell e.g. grows and replicates its DNA. The cell division takes place in M phase, which consists of mitosis 
and cytokinesis (not shown in the figure). The cell may exit the cell cycle into a resting G0 phase if the 
extracellular conditions do not favor the cell division. (Adapted from Vermeulen et al., 2003.)   
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to rearrange itself very rapidly as the cell undergo big changes such as cell cycle. 
Especially microfilaments and microtubules, polymers that are composed of actin and 
tubulin, respectively, play a crucial role in mitosis. (Nakaseko & Yanagida, 2001) 
 
The fast rearrangement capacity of microfilaments and microtubules is due to the 
constant polymerization and depolymerisation of the filaments. Polymerization and 
depolymerisation processes are slightly different with actin than with tubulin (figure 7). 
Microfilaments have plus end where the polymerization occurs and minus end that is 
depolymerizing. Actin polymerisation is ATP driven. Actin subunits bind ATP and 
when the actin is added to the polymer, ATP is hydrolysed to ADP. ADP bound actin 
dissociates from the polymer and this causes the depolymerisation. Microtubules 
consist of α- and β-tubulin dimers. (Kueh & Mitchison, 2009) Instead of ATP, tubulin 
dimers bind guanosine triphosphate (GTP) which drives the polymerization (Sept, 
2007). GTP is produced in the citric acid cycle as a byproduct of the succinate 
production (Berg et al., 2002b). It is then hydrolysed to guanosine diphosphate (GDP) 
(Sept, 2007). Microtubules polymerize and depolymerize from their plus end since 
their minus ends are embedded in nucleatic centers that are called centrosomes (H. 
Yang et al., 2010). Depolymerization occurs when the concentration of GTP bound 
tubulin dimers decreases and the hydrolysis of GTP happens more quickly than the 
addition of GTP bound dimers. When the hydrolysis of GTP reaches the plus end, the 
polymer collapses and a very fast depolymerisation occurs. This phenomenon is 
called dynamic instability. (Sept, 2007)      
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2.1.2 S phase 
 
As mentioned above, the DNA replication takes place in the S phase. In DNA 
replication two genetically identical sister chromatins are formed and they stay 
connected through the interphase. The cohesion between sister chromatids is crucial 
since the premature separation may lead to genome instability. The cohesion is 
maintained by protein complexes called cohesins that have a multiphase regulatory 
system. An important part of the regulatory system is securin, which inhibits the 
inhibitors of cohesins. (Brooker & Berkowitz, 2014) 
 
2.1.3 Mitosis and cytokinesis 
 
Mitosis is divided into five stages: prophase, prometaphase, metaphase, anaphase 
and telophase that are presented with cytokinesis in figure 8. In the beginning of 
mitosis, the cell stops migrating and receives a spherical shape. This is due to the 
new arrangement of actin filaments. (Alberts et al., 2015c, p. 890) Mitosis begins with 
the prophase. In the prophase the chromosomes begin to condensate. (Hagstrom & 
Meyer, 2003) Protein complexes, condensins I and II, play an important role in 
Figure 7. A) Polymerization of microfilaments from ATP bound actin monomers. Microfilaments 
polymerize from plus end and depolymerization from the minus end begins when ATP (T) is hydrolyzed 
to ADP (D). B) Microtubules polymerize from GTP bound tubulin dimers. When GTP (T) is hydrolyzed to 
GDP (D), depolymerization begins. Microtubules polymerize and depolymerize from plus end. (Modified 
from Kueh & Mitchison, 2009) 
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chromosome condensation and condensin II, which locates in nucleus, participates 
the condensation in prophase (Hirano, 2012). Cohesins are mostly removed from the 
arms of the chromosome but they remain in the centromere. The centrosomes move 
to the opposite sides of the cell and microtubules begin to polymerize from them. 
(O'Connor, 2008) 
 
 
Promethaphase begins when the nuclear membrane, also known as nuclear 
envelope, falls apart into several vesicles (Hagstrom & Meyer, 2003; O'Connor, 2008). 
After the disruption of nuclear envelope, cytosolic protein, condensin I, gains access 
to chromosomes and begins to collaborate with condensin II (Hirano, 2012). The 
polymerization of the microtubules continues and they begin to seek the attachment 
sites of the chromosomes (O'Connor, 2008). Microtubules attach to the kinetochores, 
protein complexes that are present at the surface of each centromere, and form a so 
called mitotic spindle (Cleveland et al., 2003). Chromosomes end up having bi-
orientation where sister chromatines are attached to the microtubules from opposite 
centrosomes (O'Connor, 2008).  
 
In metaphase the chromosomes are fully condensed and microtubules begin to pull 
them to the opposite sides of the cell. However, due to the condensation and presence 
of the cohesins, chromosomes are able to withstand the pulling (Brooker & Berkowitz, 
2014; Hagstrom & Meyer, 2003). Chromosomes are aligned in the middle of the cell 
and form a so called metaphase plate (Hagstrom & Meyer, 2003). 
 
Figure 8. Mitosis and cytokinesis. In prophase, centromeres move to the opposite sides of the cell. In 
prometaphase, nuclear membrane is broken and microtubules reach the kinetochores of the chromatins. 
During metaphase, chromatins form metaphase plate in the center of the cell. In anaphase, the sister 
chromatins are pulled away from each other and in telophase, a new nuclear membrane is formed around 
both sets of chromosomes. The cytoplasm of the cell is divided in cytokinesis. (Adapted from Saltsman, 
2005, p. 57) 
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In anaphase the cohesins are removed from the centromeres and the cohesion 
between sister chromatides is no longer maintained (Brooker & Berkowitz, 2014). 
Microtubules get shorter and centromeres move further apart and the chromosomes 
are pulled to the opposite sides of the cell (Alberts et al., 2015b, p. 981; O'Connor, 
2008). Due to the movement of centromeres, caused by the pushing and pulling by 
non-kinetochore microtubules, the cell become elongated (Scholey et al., 2016). Actin 
plays also an important role in this since the cortical flow of actin enables the 
movement of centromeres (Heng & Koh, 2010).  
 
The last phase of mitosis is the telophase in which the chromosomes reach the 
centrosomes (O'Connor, 2008). The nuclear membrane is formed around both sets 
of chromosomes creating two new nuclei (Webster et al., 2009). Chromosomes begin 
to decondensate (O'Connor, 2008).  
 
Cytokinesis is the division of the cytoplasm (O'Connor, 2008). It is not a part of mitosis 
but it belongs to the M phase and is the last step of the cell cycle. It usually begins 
during the anaphase and ends after the completion of mitosis. (Alberts et al., 2015b, 
p. 996) The division of cytoplasm is performed by a contractile ring consisting of actin 
and myosin. The actomyosin contractile ring creates a groove, a so called cleavage 
furrow, that deepens as the ring contracts. (Glotzer, 2005) After the complete 
contraction of the actomyosin ring, the daughter cells still remain connected by 
cytoplasmic bridge. The bridge can be broken and the cell membranes sealed by the 
membrane insertion and fusion. (Finger & White, 2002) When the cells are completely 
divided, the actin cytoskeleton is rearranged and the cells regain their extended shape 
(Heng & Koh, 2010).  
 
2.2 Regulation of the cell cycle 
 
The cell cycle is highly regulated process. The cell needs to ensure it has completed 
the previous phase until it can proceed to the next phase. This includes ensuring e.g. 
the errorless replication, adequate cell size and uniformity of the chromosomes. 
(Barnum & O'Connell, 2014) The cell cycle has specific checkpoints, which work as 
binary switches, either allowing or preventing the cell cycle to continue (Alberts et al., 
2015b, p. 967). The delaying of cell cycle gives time to the cell to finish the previous 
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phase and repair possible DNA damages. If the cell cannot do this, the cell cycle is 
arrested permanently, leading to cell death. (Lukas et al., 2004) The checkpoints 
arrest the cell cycle also if there is not enough energy to complete the next phase 
(Salazar-Roa & Malumbres, 2017). There are three major checkpoints in the cell 
cycle: restriction point (or start) in late G1, G2/M transition and spindle checkpoint in 
metaphase/anaphase transition (Alberts et al., 2015b, p. 968; Molinari, 2000). The 
main checkpoints are illustrated in figure 9. 
 
 
2.2.1 Cell cycle checkpoints 
 
Restriction point is the first main checkpoint in the cell cycle. It is located in the late 
G1 phase and it acts as a starting point for cell division. Once the restriction point has 
been passed, the cell is committed to begin the DNA replication and once it is started, 
it must be finished. Restriction point is also the point after which the growth factors do 
not affect the cell cycle anymore (Blagosklonny & Pardee, 2002). In order to pass the 
restriction point, the DNA of the cell must be undamaged so that the cell will not 
replicate the damaged sequences. In addition, the extracellular environment must be 
favourable. (Alberts et al., 2015b, p. 973; Blagosklonny & Pardee, 2002) 
Figure 9. The main checkpoints of the cell cycle: the restriction point or start at the end of G1 phase, 
G2/M transition and spindle checkpoint between metaphase and anaphase. (modified from Alberts et al., 
2015b, p. 968.) 
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G2/M transition is located between the G2 and M phase and it is a starting point for 
mitosis. It is an important checkpoint since it helps maintaining the genomic stability 
by preventing the proliferation of cells with damaged DNA. (Stark & Taylor, 2006) 
G2/M transition verifies that DNA replication in S phase has been successful and offers 
time for DNA repair if necessary (Blagosklonny & Pardee, 2002). 
    
The spindle checkpoint is the last of the main checkpoints in the cell cycle and it is 
located between metaphase and anaphase. The main responsibility of the spindle 
checkpoint is to maintain the genomic stability by ensuring that the chromosomes are 
segregated accurately. (Lara-Gonzalez et al., 2012) This checkpoint delays the 
progression to anaphase if the spindle microtubules are disrupted or they are not 
correctly attached to the chromosomes (Gorbsky, 2015). The spindle checkpoint 
recognizes the unattached kinetochores and allows the cell to continue to anaphase 
once all the kinetochores are attached to microtubules (Lara-Gonzalez et al., 2012). 
 
2.2.2 Overview on checkpoint regulatory system  
 
The cell cycle has a complicated regulatory system but its main participants are the 
cyclin-dependent kinases (Cdks) that are activated by cyclins (Molinari, 2000). Cyclin-
Cdk complexes regulate e.g. the proceeding through the restriction point and G2/M 
transition (Alberts et al., 2015b, p. 970). The activation of Cdks is dependent on the 
availability of specific cyclins, which is regulated during the cell cycle. Cyclins also 
direct the cyclin-Cdk complex to specific targets. (Molinari, 2000) There are several 
different types of cyclins that are categorized by the cell cycle stage they are present 
in: G1/S cyclins, S cyclins and M cyclins. Their concentration varies during the cell 
cycle (figure 10). (Alberts et al., 2015b, p. 969) Cyclin-Cdk complexes are not fully 
activated until Cdk-activating kinase (CAK) phosphorylates them on specific 
threonine. (Molinari, 2000) Cdks can be inactivated by additional phosphorylation of 
tyrosin or by Cdk inhibitor proteins (CKIs) (Barnum & O'Connell, 2014). When 
activated, Cdks activate their target proteins by phosphorylating them and in that way 
regulate the occurrence of cell cycle events (Alberts et al., 2015b, p. 969). The 
phosphorylation of target proteins is driven by the hydrolysis of ATP that is bound to 
each Cdk (Peyressatre et al., 2015).  
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The spindle checkpoint is regulated by anaphase promoting complex (APC) (Alberts 
et al., 2015b, p. 970). APC is an ubiquitin ligase that marks its target proteins for 
degradation. The activator of the APC, Cdc20, is unable to activate APC until all the 
kinetochores are properly attached to the mitotic spindle. (Reddy et al., 2007) The 
regulation of the activation capability of Cdc20 seems to be ATP-dependent 
(Miniowitz-Shemtov et al., 2012; Miniowitz-Shemtov et al., 2010). After activation, 
APC degrades its targets, securin and S- and M-cyclins (Alberts et al., 2015b, p. 971; 
Reddy et al., 2007). The degradation of cyclins is essential for cell cycle to finish 
(Alberts et al., 2015b, p. 971). As described earlier, securin plays a role in regulatory 
system of the cohesion between sister chromatins and after its degradation, cohesins 
are inhibited and sister chromatins are able to detach from each other. This chain of 
events enable the transition to anaphase.   
 
2.3 Energy consumption of the cell cycle  
 
Cell division is a complex process consisting of multiple events and therefore it has 
high energy demands. DNA synthesis and mitosis are energy-dependent processes 
that require oxidative phosphorylation. In the case of ATP depletion, the cell cycle 
Figure 10. The cyclins activate and direct the cyclin-dependent kinases (Cdks) that regulate the cell 
cycle. The activation of Cdks is regulated by altering the concentrations of specific cyclins during the cell 
cycle. The cyclins are categorized based on the cell cycle phase they are present in. Cyclin bound Cdks 
control the proceeding through start checkpoint and G2/M transition. Spindle checkpoint is controlled by 
anaphase promoting complex (APC). (Alberts et al., 2015b, p. 969.) 
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checkpoints are activated, since the cell can proceed to the next phase of the cycle 
only if it has sufficient resources to finish it. Checkpoint activation due to the ATP 
depletion seems to be Cdk-mediated and thus the cell cycle arrests take place 
especially before the beginning of S phase or at G2/M transition. (Salazar-Roa & 
Malumbres, 2017). However, defects in the cell cycle regulation may lead to 
checkpoint dysfunction, meaning that the cells may pass the checkpoint when they 
normally would not. This may lead to apoptosis or cancer. (Barnum & O'Connell, 
2014) How well the cell can withstand the energy shortage, depends on the cell type 
(Wieser & Krumschnabel, 2001).  
 
There are multiple energy-dependent processes in the cell cycle and here only few of 
them are briefly mentioned. Protein synthesis seems to be the most ATP consuming 
process in the cell (Buttgereit & Brand, 1995; Pontes et al., 2015). The protein 
synthesis can be inhibited due to the ATP shortage and this has direct effects on the 
cell cycle since many proteins play essential role in it (Freudenberg & Mager, 1971; 
Polymenis & Aramayo, 2015). Similarly, the replication and synthesis of DNA in S 
phase requires ATP and if there is a shortage of it, the DNA synthesis is inhibited 
(Enomoto et al., 1981). Also, the cell cycle regulation by Cdks and APC requires ATP 
as described in chapter 2.2.2.  
 
One essential function during cell cycle is the DNA repair system that is activated 
when DNA is damaged or incorrectly replicated. The type of the DNA damage can 
vary and can be roughly categorized to single strand breaks and double strand 
breaks. There are different repair mechanisms for each type of damage. (Houtgraaf 
et al., 2006) Regardless of the mechanism, DNA repair requires the remodelling of 
the chromatin structure in order to succeed (Liu et al., 2012). Chromatin remodelling 
is highly ATP-dependent process since the chromatin-remodelling complexes need 
the energy from ATP hydrolysis to function (Lans et al., 2012). ATP dependent actin 
polymerization is also required in DNA repair (Andrin et al., 2012). If the DNA repair 
system does not function properly due to the energy shortage, the cell cycle is 
arrested in G1/S or in G2/M transition (Houtgraaf et al., 2006).    
 
The cytoskeleton plays an important role in mitosis. As discussed in chapter 2.1.1, 
the polymerisation of actin and tubulin is driven by the binding of ATP and GTP, 
respectively (Kueh & Mitchison, 2009; Sept, 2007). It is thus clear that rearrangement 
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of microfilaments is an ATP-depending process and the disruption of actin filaments 
may delay the mitosis. Actin disruption has also been linked to cell cycle arrest at G1 
phase. (Heng & Koh, 2010) However, also depolymerisation of microtubules seems 
to require ATP and ATP depletion may result in microtubule stabilization, leading to 
mitotic arrest (Spurck & Pickett-Heaps, 1987).  
 
2.4 Cell cycle affecting toxins 
 
Many toxins affect cell cycle and its regulatory system often via DNA damage. Agents 
that damage DNA or cause chromosomal aberrations are called genotoxins (Phillips 
& Arlt, 2009). The DNA damage can lead to mutations and initiate carcinogenesis 
(Kaufmann, 2007). Cell cycle checkpoint system should not pass cells with damaged 
DNA content to S phase or mitosis, but when the checkpoint control is incompetent, 
e.g. due to the mutations, this may happen and lead to proliferation of malignant cells. 
Despite their potential carcinogenicity, many cell cycle affecting genotoxins can be 
utilized in cancer treatment due to their cell cycle arresting effects. (Shapiro & Harper, 
1999) Genotoxins can interfere with the cell cycle via multiple mechanisms and some 
of the most relevant ones are introduced in the next chapter. Understanding these 
mechanisms is important when evaluating the underlying mechanisms of the possible 
association between mitochondrial toxins and DNA damage. 
 
2.4.1 Mechanisms of cell cycle affecting genotoxins 
 
Here, three groups of cell cycle affecting genotoxins are introduced: microtubule-
targeting agents, topoisomerase inhibitors and DNA alkylating agents. Microtubule-
targeting agents disrupt the mitotic spindle and arrest the cell cycle at 
metaphase/anaphase transition. These agents have been used in the treatment of 
cancer and they can be divided into two categories based on their mechanism: 
microtubule stabilizers and destabilizers. (Fanale et al., 2015) Microtubule stabilizers 
prevent the depolymerization of the microtubules by binding directly to tubulin dimers. 
The most well-known binding site is the taxoid site, which is located in the β-tubulin 
subunit. When the depolymerization is prevented, microtubules are not able to pull 
the sister chromatins away from each other and the cell cycle is arrested. (Field et al., 
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2013) Microtubule destabilizers prevent the polymerization of microtubules and stop 
the formation of mitotic spindle (Fanale et al., 2015). Destabilizers bind to colchicine 
or vinca alkaloid site, which are both located in β-tubulin subunit of the dimer (Bates 
& Eastman, 2017). How the microtubule stabilizers and destabilizers prevent the 
depolymerization and polymerization of microtubules, is not fully understood (Wang 
et al., 2017; H. Yang et al., 2010).  
 
Topoisomerase I and II are nuclear enzymes that can make a single strand and 
double strand break, respectively, to DNA in order to allow relaxation of supercoiled 
DNA. After the relaxation, the strands ligate back together and the structure of the 
DNA is restored. The topoisomerase I and II inhibitors can disturb this activity by 
preventing the religating of the DNA strands and thus inducing the formation of DNA 
strand breaks. (Ewesuedo & Ratain, 1997; Hande, 2008) These breaks arrest the cell 
cycle or delay it at the G2/M transition (Poot et al., 1992). Due to this activity, 
topoisomerase I and II inhibitors are used as anticancer drugs (Ewesuedo & Ratain, 
1997; Mikhailov et al., 2004). 
 
DNA alkylating agents are a wide group of compounds that cause DNA damage by 
adding alkyl groups to bases of the DNA strand. The alkyl group added depends on 
the agent. (Grady & Ulrich, 2007) The addition of alkyl groups can cause base 
mispairing and block the replication (Lundin et al., 2005). Even though the DNA repair 
mechanisms of the cell can repair some of the caused DNA damage, DNA alkylation 
can lead to cell cycle arrest at G2/M transition or apoptosis (Kondo et al., 2010).  
 
2.4.2 Markers for genotoxicity 
 
Genotoxicity can be detected with the aid of specific markers. These markers are 
developed to tag the targets that are predominantly present when cells are affected 
by genotoxins. (Khoury et al., 2016) Markers that target the phosphorylated histone 
H3 and H2Ax are very common in the detection of genotoxicity. 
 
The chromosome condensation in mitosis is correlated with the phosphorylation of 
histone H3. In mammalian cells, this phosphorylation occurs at a specific spot, at the 
serine 10 of histone H3. Phosphorylation of H3 takes place almost exclusively in 
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mitosis. It begins in prophase, becomes maximal during metaphase and is lost during 
telophase. Antibodies that specifically recognise the phosphorylated serine 10 in 
histone H3 can be used to detect mitotic cells. (Hendzel et al., 1997) As described in 
previous chapter, some genotoxic agents arrest the cell cycle during mitosis. The cell 
population treated with this kind of toxicant contains more mitotic cells than the 
unexposed cell population. Hence, the amount of phospho-histone H3 (pH3) is 
increased when the cells are damaged by mitosis arresting genotoxins. (Khoury et al., 
2016) 
 
When DNA double strand breaks are formed as a result of DNA damage, it is always 
followed by phosphorylation of histone H2Ax (Kuo & Yang, 2008). This 
phosphorylation occurs specifically at serine 139 of H2Ax (Podhorecka et al., 2010). 
In normal cells, the amount of phosphorylated H2Ax increases during S phase and 
reaches maximal level at G2/M transition due to the function of topoisomerase II 
(McManus & Hendzel, 2005). However, when the cells have been damaged by the 
double strand break inducing genotoxins, the level of phosphorylated H2Ax is clearly 
increased. Phosphorylated H2Ax is called γ-H2Ax and there are antibodies available 
that recognise it specifically. These antibodies detect DNA double strand breaks and 
can be used to investigate DNA damaging potency of drugs. (Kuo & Yang, 2008)  
 
3. High-content analysis and flow cytometry in drug toxicity testing 
 
3.1 Overview on drug toxicity testing 
 
The failure of candidate drugs at the late stage of drug development is very expensive 
and is usually due to the discovery of adverse effects (Verbist et al., 2015). Hence, 
there is a demand for predictive assays than can be used for drug safety assessment 
at the early stage of drug development (Bluemel, 2012). Drug toxicity has been 
traditionally tested in vivo by using animal models at relatively late stages of drug 
development. Animal testing is expensive and animal models do not replicate the 
human biology comprehensively. In addition, it is very slow since only one compound 
at the time can be investigated. (Shukla et al., 2010; Verbist et al., 2015)   
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Moving from in vivo tests to in vitro high-throughput techniques that are able to 
measure multiple parameters from several compounds simultaneously has been 
necessary to investigate the toxicology of compounds effectively (Verbist et al., 2015). 
The use of human-derived cell lines may provide better biomarkers of exposure to 
toxicants and lead to better understanding of the mechanisms of toxicity (Shukla et 
al., 2010; Verbist et al., 2015). In addition, in vitro assays are less expensive and can 
be performed at the earlier stage of development (Verbist et al., 2015). 
 
Even though it is desired to have a lot of data in a short period of time, the data amount 
is also one of the biggest challenges of high-throughput techniques. The large amount 
of data is not only laborious and slow to handle but makes it difficult to find the relevant 
information. (Pedreira et al., 2013; Zanella et al., 2010) The development of data 
analysing tools that are able to extract the relevant data, is essential but difficult 
(Pedreira et al., 2013). Also the development of toxicity assays, including the choice 
of cell source, requires careful planning and may be challenging (Zanella et al., 2010).  
 
The mechanisms of two high-throughput techniques, high-content analysis (HCA) and 
flow cytometry (FC), will be briefly explained later. Both of these techniques are based 
on the utilization of fluorescence, which will be covered next.  
 
3.2 Immunofluorescence  
 
Immunofluorescence (IF) is a technique that can be used to determine the structure 
or the processes of the cell (Hoff, 2015). It is based on fluorochrome bound antibodies 
that bind to their specific targets, antigens. The level of selectivity and affinity that 
antibodies have for the epitopes of their antigens determines the accuracy and 
sensitivity of the assay. However, the preservation of the cells and their possible 
autofluorescence as well as the quality of the fluorescence detection device are 
factors that influence optimal detection. (Fritschy & Härtig, 2001) Monoclonal 
antibodies that bind only to one epitope give better results than polyclonal antibodies 
that bind to several epitopes (Hoff, 2015).  
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Immunofluorescence can be either direct or indirect (figure 11). In direct IF the primary 
antibody is tagged with a fluorochrome and it binds to its antigen directly. The indirect 
IF has two separate steps. First, the primary antibody, without a fluorochrome 
attached to it, binds to the antigen. In the second step, the fluorochrome-tagged 
secondary antibody binds to the primary antibody. Indirect IF requires two incubation 
steps and is therefore slower than direct IF. However, in indirect immunofluorescence 
more than one secondary antibody can bind to the primary antibody. This leads to the 
amplification of the signal and less primary antibody can be used. (Hoff, 2015) 
 
 
 
In order to bind to the primary antibody, the secondary antibody needs to be targeted 
against the host species of the primary antibody. For this reason, the matching 
primary and secondary antibodies can never be derived from the same host species. 
(Donaldson, 2015) Similarly, if there are more than one target that is detected, the 
host species of the used primary antibodies need to be different. Otherwise the 
secondary antibody will bind to all of them and the different targets cannot be 
distinguished. (Hoff, 2015) 
 
Not all fluorescent dyes are conjugated to antibodies. Some fluorescent dyes bind 
directly and specifically to their target. An example is Hoechst DNA stains that bind 
directly to DNA. (Greb, 2012) Fluorescent dyes can also be conjugated with other 
compounds that have the ability to bind specifically to their cellular targets. An 
example is phalloidin, a toxin that binds directly to filamentous actin. When phalloidin 
is conjugated with fluorochrome, it can be used to detect actin. (Tang et al., 1989)  
Figure 11. The difference of direct and indirect immunofluorescence (IF). In direct IF, the fluorochrome 
bound antibody binds directly to its target epitope. In indirect IF, primary antibody binds to its epitope 
and secondary antibody that is bound to the fluorochrome, binds to the primary antibody. (Hoff, 2015) 
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3.3 High-content analysis 
 
High content analysis (HCA) or high-content screening (HCS) is a technique that 
integrates cell sample preparation, immunofluorescence, automated fluorescence 
microscopy and image analysis (Abraham et al., 2004). It enables large-scale 
screening of cells with subcellular spatial resolution. It is possible to measure 
simultaneously multiple cell features, such as nuclear area, proliferation, morphology 
and mitochondrial function. (Abraham et al., 2008) Several integrating HCA tools have 
been developed in addition to imaging instrumentation, including software with 
different bioapplications and data analysis tools. With these tools, both living and fixed 
cells can be analysed. (Abraham et al., 2004) Live-cell imaging enables also the 
kinetic monitoring of the cell in real time (O'Brien et al., 2006). In pharmaceutical 
industry, HCA is used e.g. for an early drug discovery and for toxicology screening 
(Abraham et al., 2008).  
 
The HCA is based on the imaging of the fluorescent-dyed cells that are plated to 
microtiter plates (O'Brien et al., 2006). The images are taken by the automated, 
camera containing fluorescent microscope system that is located in a box (Buchser 
et al., 2004). The pixels of the images are segmented into objects. The features of the 
objects, such as intensity, size, count or shape, are then determined. (Trask & 
Johnston, 2015) What the object is, depends on the fluorescent-dyed target. For 
example, when nuclear specific stain is used, the object is the nucleus. Nuclear 
specific stains are commonly used to identify independent cells from the images and 
to determine an object mask, which defines the borders of the cells. The objects in 
other channels, e.g. tubulin fibers, are measured only inside these masks and the 
data can be linked to the correct cell. In HCA, multiple imaging channels can be used 
for different fluorescent stains with different wavelengths and several features from 
multiple cell compartments can be measured simultaneously. (Buchser et al., 2004)  
 
3.4 Flow cytometry 
 
In vitro drug toxicity can be measured by using flow cytometry (FC). It is a quick and 
accurate method to investigate both cytotoxic and genotocix effects. (Dallas & Evans, 
1990) Flow cytometry utilizes light-scattering and fluorescence emission to analyse 
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single cells in a cell population (Díaz et al., 2010). It is possible to determine several 
cellular parameters, such as size, count, viability and data about cell cycle, very 
rapidly (McFarland & Harkins, 2010). The capacity of the technique depends on the 
sophistication of the device but even the conventional cytometers can analyse 5000 
cells per second (Díaz et al., 2010). However, also the type of the cells affect the rate 
of the analysis. For example, large and easily aggregated cells must be processed 
slower than small, individual ones in order to avoid blockages in the device. (Edwards 
et al., 2007) 
 
In FC, the sample is a suspension containing detached cells usually in a microtiter 
plate. Even though FC has conventionally been used for detecting characteristics of 
cells, also other particles such as chromosomes, can be used as a sample. (Edwards 
et al., 2007) The cells flow individually through a light beam in a narrow capillary. The 
light scattering and fluorescence emissions are collected by the detectors and the 
information is correlated to various cell parameters. For example, the forward-
scattered light correlates with the cell size and the side-scattered light give information 
about the internal complexity of the cell. The light-scattering gives information of the 
intrinsic properties of the cell. (Alvarez-Barrientos et al., 2000) Additional information 
about extrinsic properties, such as intra- and extracellular content and processes, can 
be gained when combining immunofluorescence with FC. (Krutzik & Nolan, 2006). 
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III EXPERIMENTAL PART 
 
4. Materials and methods 
 
4.1 Cell lines 
 
The cell line used in this thesis was C3A, a clonal derivative of human hepatocellular 
carcinoma HepG2 ([HepG2/C3A, derivative of Hep G2 (ATCC HB-8065)] ATCC® 
CRL-10741™). The cell line was acquired from ATCC and the passage number 
before thawing was unknown. Another cell line used in this research was TK6 (ATCC 
CRL-8015), a thymidine kinase heterozygote cell line isolated from the human 
lymphoblastoid line HH4. HH4 line was derived from the WIL-2 cell line. The cells 
were acquired from ATCC. The TK6 cells were provided and cultivated by Research 
Associate Merja Valovirta.  
 
Since the focus in this research was in HepG2/C3A cells, in this thesis the term cell 
refers to them unless stated otherwise. 
 
4.2 Cultivation and subculturing 
 
HepG2/C3A cells were cultivated in 75 cm2 flasks in Dulbecco’s Modified Eage 
Medium (DMEM) with supplements. The composition of medium is shown in table 1. 
The cells were grown in an incubator (HERAcell, Heraeus, Kendro Laboratory 
Products, UK) at +37 ˚C and 5% CO2. The handling of the cells was done in laminar 
flow hood (Kojair, Finland). 
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Table 1. The content of the medium. 
Proportion Substance 
86.5% Dulbecco’s Modified Eagle Medium, Cat.no. 41965, Gibco, UK 
1% 100 mM Sodium Pyruvate, Gibco, UK 
0.5% 1M HEPES Buffer, Sigma, UK 
1% 100x MEM NEAA (Minimum Essential Medium, Non-Essential Amino Acids), 
Gibco, UK  
10% Heat Inactivated FBS (Fetal Bovine Serum), Gibco, South America 
1% Penicillin-Streptomycin, Sigma, Israel 
 
The cells were subcultivated twice a week, after the confluency was approximately 
60% (figure 12). The confluency was estimated by observing the cells with microscope 
(Olympus CKX53, Japan). The medium, sterile Dulbecco’s phosphate-buffered saline 
(PBS, Gibco, UK) and 0.05% Trypsin-EDTA (Gibco, Canada) were preheated to +37 
˚C in a water bath (Julabo, Germany). The old medium was removed and the cells 
were washed twice with 10 ml of PBS. To detach the cells, 5ml of Trypsin-EDTA was 
added to the flask. The cells were incubated first at room temperature for 1–2 minutes 
after which most of the trypsin was removed from the flask. The incubation was 
continued at +37 ˚C and 5% CO2 for 6 minutes. 5 ml of fresh medium was added to 
the flask and the cell suspension was mixed roughly through a 300 µl pipette tip in 
order to break aggregates.  
 
 
 
Figure 12. Phase-contrast image of HepG2/C3A cells with 100x magnification in the cultivation flask. The 
confluency of the cells is approximately 60% and the cells can be subcultivated. 
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For the cell count, 1:5 dilution was made by mixing 10 µl of cell suspension with 40 µl 
of PBS. C-chip was used for the cell count and 10 µl of the diluted suspension was 
pipetted into it. The average of the cell counts from the four corner squares was used 
as a final cell count. The needed volume of undiluted cell suspension was calculated 
based on the cell count and added to a new cultivation flask with fresh medium. The 
total volume of medium and cell suspension was 15 ml. The subcultivation ratio was 
dependent on when the cells were needed the next time and for this, table 2 was used 
as guidance. After each subcultivation the passage number of the cells increased by 
one. The cells were not subcultivated over passage number 30 in order to prevent 
any changes in the cell line.  
 
Table 2. The subcultivation ratio for different cultivation times.   
Growth Time  Cell count per 15 ml 
2 days 6*102 
3 days 3*102 
4 days 1.5*102 
5 days 0.75*102 
 
4.3. Cell plating 
 
For the assays, the cells were plated to poly-d-lysine coated 96-well plates (Biocoat, 
Corning, USA). The trypsinization protocol was identical to the one described in 
previous chapter. Before cell counting the cell suspension was passed through a 21 
G needle to ensure that the cells have detached from each other. After cell counting 
the cell suspension was diluted with fresh medium and spread to the plates. The 
dilution ratio was dependent on the incubation time. The incubation times were 24 h 
and 48 h, and the number of cells per well was 11 000 and 8 000, respectively. The 
total volume of the cell suspension in each well was 100 µl. The plates were incubated 
at room temperature for one hour and placed in the incubator (+37 ˚C, 5% CO2). 
 
The TK6 cells were plated by pipetting robot Microlab Star (Hamilton, USA). The cell 
plating protocol of the pipetting robot was part of the FC procedure for TK6 cells that 
has been established at Orion. 
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4.4 Addition of compounds to the cells  
 
The cells were treated with selected compounds and controls that are introduced later. 
All the compounds used were of analytical grade. Stock solutions were prepared by 
dissolving the compounds in dimethyl sulfoxide (DMSO, Sigma, UK). The 
concentration of the stock solutions was 100 times stronger than the top concentration 
added to the cells.  
 
For the HCA the dilution series were done by diluting stock solutions with DMSO. 
Dilution series were further diluted in medium so that the final concentration of each 
solution was three times stronger than the concentration added to the cells. The 
compounds were added to the cells after 24 h incubation. The old medium was 
discarded, the cells were washed twice with 100 µl PBS and 100 µl of new, pre-heated 
medium was added to each well. The compound solutions were diluted into intended 
concentrations when 50 µl of them was added to the cells and mixed with the medium. 
At least one column in each microtiter plate was left without compounds and it acted 
as a negative control. The final DMSO concentration in each well was 1%. An example 
of the dilution protocol for HCA can be seen in figure 13. After the addition of 
compounds to the cells, the plates were incubated at incubator for 4 h, 6 h or 24 h. 
The plates that initially contained 11 000 cells per well were incubated either 4 h or 6 
h and the plates with initial number of 8 000 cells per well were incubated for 24 h. 
 
For the FC the same stock solutions were used as for HCA but the dilution series 
and the addition of the compounds to the cells were done by the pipetting robot. The 
procedure of the pipetting robot for both HepG2/C3A and TK6 cells has been 
established at Orion. Four wells per plate were left without compounds and 
contained 1% DMSO in medium. The plates for FC were incubated for 24 h.   
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4.5 HCA assay 
 
In this research, 16 different compounds were tested. In addition, five positive controls 
were used. The mechanisms of toxicity and the top concentrations of the used 
compounds are listed in table 3. The chosen concentrations of controls are listed in 
table 4.  
 
The cells were plated as described in chapter 4.3 and the compounds were added to 
the cells the next day. The dilution series of four compounds were applied to the plates 
at once. The plate map of the assays and the dilution series of the compounds are 
illustrated in figure 14. The compounds were added as described in chapter 4.4.  Two 
sets of three parallel plates per both time points, 6 h and 24 h, were handled 
simultaneously, meaning that each compound was applied to 12 plates.  
 
 
 
Figure 13. An example of the dilution protocol of concentration series for the HCA. The concentration of 
stock solution was 100 times stronger than the top concentration at the cells. The concentration series 
were diluted from the stock solution with DMSO. The series were further diluted with medium so that the 
concentration was three times stronger than the final concentrations at the cells. Finally, the compounds 
were diluted to the final concentrations when they were applied to the cells. 
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Table 3. The compounds used in the research, their maximum concentration at the cells and their 
mechanism of toxicity. 
Compound Top 
concentration 
(µM) 
Supplier, 
Country 
Stock keeping 
unit 
Mechanism of 
toxicity 
Reference 
2,4-dinitrophenol 200 Aldrich, 
USA 
D198501 Uncoupler (Grundlingh et 
al., 2011) 
Amiodarone HCl 20 Sigma, 
USA 
A8423 Uncoupler, complex 
I inhibitor, β-
oxidation inhibitor 
(Serviddio et 
al., 2011) 
Buspirone HCl 200 Sigma, 
USA 
B7148 Negative control, 
complex I inhibitor 
Dykens et al. 
(2008b) 
Entacapone 200 Sequoia, 
UK 
SRP10885e Negative control, 
uncoupler 
(Grunig et al., 
2017; Longo et 
al., 2016) 
Fluoxetine 100 Sigma, 
USA 
F0253000 Uncoupler, complex 
V inhibitor 
(de Oliveira, 
2016) 
Levosimendan 200 Orion, 
Finland 
- Uncoupler  
Metformin HCl 200 Sequoia, 
UK 
SRP02280m Negative control, 
complex I inhibitor 
(Dykens et al., 
2008a) 
Nefazodone HCl 50 Sequoia, 
UK 
SRP03327n Complex I and IV 
inhibitor 
(Dykens et al., 
2008b) 
Nimesulide 200 Sigma, 
Italy 
N1016 Uncoupler, MPT 
inducer 
(Mingatto et 
al., 2002) 
Oligomycin 2.5 Agilent*, 
USA 
103015-100 Complex V inhibitor (Jonckheere et 
al., 2012) 
Paclitaxel 8 Sigma, 
USA 
T7402 Microtubule 
stabilizer 
(L. Yang et al., 
2010; 
Zacharaki et 
al., 2013) 
Phenformin HCl 200 Sigma, 
China 
P7045 Complex I inhibitor (Dykens et al., 
2008a) 
Rotenone 1 Sigma, 
USA 
R8875 Complex I inhibitor (Heinz et al., 
2017) 
Staurosporine 2 Enzo, 
USA 
ALX380014M005 respiratory 
inhibition, Cdk1 
inhibitor 
(Duan et al., 
2003; 
Vermeulen et 
al., 2003) 
Tolcapone 200 Sequoia, 
UK 
SRP02376t Uncoupler (Grunig et al., 
2017; Longo et 
al., 2016) 
Troglitazone 
 
100 Sigma, 
USA 
T2573 Complex II-V 
inhibitor, MPT 
inducer 
(Masubuchi et 
al., 2006; 
Nadanaciva et 
al., 2007) 
* From Seahorse XF Cell Mito Stress Test kit 
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Table 4. The positive controls, their concentrations at the cells and their mechanism of toxicity. All five 
controls were used in HCA assay. In FC assay, CCCP, MMS and Vinblastine were used 
Control 
 
Concentration 
(µM) 
Supplier, 
Country 
Stock keeping 
unit 
Mechanism 
of toxicity 
Reference 
CCCP 50 Alfa Aesar, 
Germany 
 
L06932 
 
Cytotoxicant, 
Uncoupler 
(Ganote & 
Armstrong, 
2003) 
Griseofulvin 50 Sigma, China 
 
G4753 Microtubule 
stabilizer 
(Zacharaki et 
al., 2013) 
MMS 1000 Aldrich, USA 129925 DNA 
methylator 
(Lundin et al., 
2005) 
Paclitaxel 2 Sigma, USA 
 
T7402 Microtubule 
stabilizer 
(Zacharaki et 
al., 2013) 
Vinblastine 0.01 Sigma, USA V1377 Microtubule 
destabilizer 
(Weaver & 
Cleveland, 
2005) 
 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Griseofulvin/ 
Paclitaxel 
DMSO Compound a 
- 
a 
2 
a 
2 
a 
1.5 
a 
2 
a 
2 
a 
2 
a 
3 
a 
3 
CCCP 
B Griseofulvin/ 
Paclitaxel 
DMSO Compound a 
- 
a 
2 
a 
2 
a 
1.5 
a 
2 
a 
2 
a 
2 
a 
3 
a 
3 
CCCP 
C Griseofulvin/ 
Paclitaxel 
DMSO Compound b 
- 
b 
2 
b 
2 
b 
1.5 
b 
2 
b 
2 
b 
2 
b 
3 
b 
3 
CCCP 
D Griseofulvin/ 
Paclitaxel 
DMSO Compound b 
- 
b 
2 
b 
2 
b 
1.5 
b 
2 
b 
2 
b 
2 
b 
3 
b 
3 
CCCP 
E Vinblastine DMSO Compound c 
- 
c 
2 
c 
2 
c 
1.5 
c 
2 
c 
2 
c 
2 
c 
3 
c 
3 
MMS 
F Vinblastine DMSO Compound c 
- 
c 
2 
c 
2 
c 
1.5 
c 
2 
c 
2 
c 
2 
c 
3 
c 
3 
MMS 
G Vinblastine DMSO Compound d 
- 
d 
2 
d 
2 
d 
1.5 
d 
2 
d 
2 
d 
2 
d 
3 
d 
3 
MMS 
H Vinblastine DMSO Compound d 
- 
d 
2 
d 
2 
d 
1.5 
d 
2 
d 
2 
d 
2 
d 
3 
d 
3 
MMS 
Figure 14. The plate map of the HCA assay. The concentration series of four compounds were on one 
plate. The top concentration was in column 3 and the numbers in columns 4–11 are the dilution factors. 
The positive controls were on the sides of the plate and the negative control (untreated cells) in column 
2.  
 
After the cells had been incubated with the compounds for the correct amount of time, 
the cells were fixed. The medium and the compounds were discarded from the wells 
at the time points 4 h, 6 h or 24 h. The cells were fixed by adding 100 μl 4% (v/v) 
paraformaldehyde (PFA) to the wells. PFA was diluted from 16% (w/v) PFA (Electron 
Microscopy Sciences, USA) with non-sterile PBS. Non-sterile PBS was prepared by 
mixing 100 ml of Dulbecco’s Phosphate Buffered Saline (10x) (Gibco, UK) with 900 
ml of sterile water (Baxter, Switzerland). The cells were incubated with PFA for 15 
minutes at room temperature. PFA was discarded and the cells were washed three 
times with 100 μl non-sterile PBS. 
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Before the immunolabeling, the permeabilization and blocking of the cells was 
performed. Permeabilization was done by adding 100 μl of 0.2% (w/v) TritonX-100 
(Sigma, USA) in PBS to the wells. The cells were incubated for 15 minutes at room 
temperature. TritonX-100 was poured away and the cells were blocked with 3% (w/v) 
bovine serum albumin (BSA, Sigma, USA) in PBS. The cells were incubated with BSA 
for 15 minutes at room temperature. BSA was discarded from the cells.  
 
Antibodies used in this research can be seen in table 5. The concentrations of the 
antibodies are presented in table 8. The primary antibodies were diluted with 3% BSA 
and 50 μl was added per well. The plates were set into microplate shaker and the 
cells were incubated with the primary antibodies overnight at +4 ˚C and shaking 250 
rpm. Since there were three different primary antibodies from two different hosts, it 
was not possible to apply all of them to same plates. Hence, one set of three parallel 
plates per one time point was labelled with γH2Ax and the other set with pH3. Both 
sets included anti-tubulin, phalloidin and Hoechst.  
 
Next day, the assay was continued. The primary antibodies were poured away and 
the cells were washed three times with 100 μl PBS. The secondary antibodies and 
fluorescence dyes were diluted with 3% BSA and added to the cells, 50 μl per well. 
Plates were incubated for 1 h in the dark and at room temperature. The cells were 
washed four times with 100 μl PBS and 150 μl PBS was left in the wells. The plates 
were sealed with non-transparent tape and stored in the dark, at +4 ˚C.  
 
Cellomics ArrayScan VTI (Thermo Fischer Scientific, USA) was used for the imaging 
of the cells. All the plates were scanned with Cellomics by using bioapplication 
Morphology V.4. Approximately 500 cells per well was imaged. Nuclear stain, 
Hoechst, was selected for the channel 1 and was used for identifying the cells and 
determining the object mask (figure 15A). The objects in other channels were 
measured only inside the object mask (figure 15B). The parameters and the channels 
used in this research are listed in table 6. 
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Table 5. The antibodies and fluorescence dyes used. 
Antibody Host Stock keeping 
unit 
Supplier Country 
Primary antibodies 
Phospho-gamma 
γH2Ax pSer139 
Rabbit PA1-25001 Thermo Fischer 
Scientific 
USA 
Phospho-Histone H2Ax 
Ser139  
Rabbit LF-PA0025 Thermo Fischer 
Scientific 
South Korea 
Phospho-histone H3 
(pH3) Ser10 
Mouse 9706 Cell Signaling 
Technologies 
USA 
Anti-beta tubulin Mouse ab131205 Abcam USA 
Anti-beta tubulin Rabbit ab179513 Abcam USA 
Secondary antibodies 
Alexa Fluor® 546, anti-
rabbit IgG 
Goat A11010 Thermo Fischer 
Scientific 
USA 
Alexa Fluor™ Plus 555, 
anti-mouse IgG 
Goat A32727 Thermo Fischer 
Scientific 
USA 
Alexa Fluor® 633, anti-
rabbit IgG 
Goat A21071 Thermo Fischer 
Scientific 
USA 
Alexa Fluor™ Plus 647, 
anti-mouse IgG 
Goat A32728 Thermo Fischer 
Scientific 
USA 
Fluorescence dyes 
Hoechst 33342 – H3570 Thermo Fischer 
Scientific 
USA 
Alexa Fluor™ 488 
phalloidin 
– A12379 Thermo Fischer 
Scientific 
USA 
 
Figure 15. HepG2/C3A cells without compound treatment taken by Cellomics Array Scan VTI with 20x objective. 
A) Channel 1 shows the nuclear stain, Hoechst, that is used to define the borders of the nuclei (shown in green). 
Nuclei are used to determine the object mask (in yellow) that defines the cells. B) Channel 3 shows anti-tubulin and 
the image analysis measures the tubulin fibers (shown in pink) only within the object mask. Therefore, the data 
from different channels can be linked together to the correct cell.  
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Table 6. The list of features measured from different channels in image analysis. All features are included 
in Morphology V.4 bioapplication.   
Fluorescent probe + primary 
antibody 
Imaging Channel Feature name 
Hoechst 33342 Channel 1 Nuclear area 
Hoechst 33342 Channel 1 Average intensity of nucleus 
Hoechst 33342 Channel 1 Cell count per field 
Alexa 546 + γH2Ax Channel 2 Member count per cell 
Alexa 546 + γH2Ax Channel 2 Average intensity of the 
members per cell 
Alexa 555 + pH3 Channel 2 Member count per cell 
Alexa 555 + pH3 Channel 2 Average intensity of the 
members per cell 
Alexa 647 + Anti-tubulin Channel 3 Fiber alignment 1 
Alexa 647 + Anti-tubulin Channel 3 Fiber alignment 2 
Alexa 647 + Anti-tubulin Channel 3 Average intensity of the fibers 
Alexa 647 + Anti-tubulin Channel 3 Average area of the fibers 
Alexa 647 + Anti-tubulin Channel 3 Fiber count  
Alexa 633 + Anti-tubulin Channel 3 Fiber alignment 1 
Alexa 633 + Anti-tubulin Channel 3 Fiber alignment 2 
Alexa 633 + Anti-tubulin Channel 3 Average intensity of the fibers 
Alexa 633 + Anti-tubulin Channel 3 Average area of the fibers 
Alexa 633 + Anti-tubulin Channel 3 Fiber count  
Alexa 488 phalloidin Channel 4 Fiber alignment 1 
Alexa 488 phalloidin Channel 4 Fiber alignment 2 
Alexa 488 phalloidin Channel 4 Average intensity of the fibers 
 
4.6 Flow cytometry DNA damage assay 
 
Flow cytometry DNA damage assay was performed with both HepG2/C3A and TK6 
cells. The cells from both cell lines were plated as described in chapter 4.3. The same 
16 compounds that were used in HCA assay were tested also in FC. In FC, three 
positive controls were used: CCCP, vinblastine and MMS. The details of the 
compounds and controls are shown in tables 3 and 4 respectively. The compounds 
were plated as described in chapter 4.4. The plate map of the FC assay for 
HepG2/C3A cells is illustrated in figure 16.    
 
For the DNA damage assay, Beta MultiFlow™ DNA Damage kit (Litron Laboratories, 
USA), containing p53, γH2Ax and pH3 markers, was used. The kit included materials 
for complete labelling solution that was prepared and its content is shown in table 7. 
The addition of complete labelling solution to the TK6 cells was done with pipetting 
robot and according to the previously established FC protocol. The TK6 cells were 
incubated at room temperature for 15 minutes before they were screened with flow 
cytometer (iQue screener, Intellicyt, USA). For the HepG2/C3A cells, the labelling 
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solution was mixed with StemPro® Accutase® (Gibco, USA) (2:1). The medium from 
the cells was discarded and 50 μl of the mixture of complete labelling solution and 
Accutase® was added to the cells. The cells were incubated at +37 ˚C, 5% CO2 for 
30 minutes. The detached cells were gently mixed with the solution to ensure their 
proper detachment. The cells and the solution was transferred into U bottom 96-well 
plates (Falcon™ Polystyrene, Corning, USA). The plates were screened using flow 
cytometer.  
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Compound 
a 1 
a 
3 
a 
5 
a 
7 
a 
9 
a 
11 
a 
13 
a 
15 
a 
17 
a 
19 
CCCP CCCP 
B Compound 
a 2 
a 
4 
a 
6 
a 
8 
a 
10 
a 
12 
a 
14 
a 
16 
a 
18 
a 
20 
CCCP CCCP 
C Compound 
b 1 
b 
3 
b 
5 
b 
7 
b 
9 
b 
11 
b 
13 
b 
15 
b 
17 
b 
19 
Vinblastine Vinblastine 
D Compound 
b 2 
b 
4 
b 
6 
b 
8 
b 
10 
b 
12 
b 
14 
b 
16 
b 
18 
b 
20 
Vinblastine Vinblastine 
E Compound 
c 1 
c 
3 
c 
5 
c 
7 
c 
9 
c 
11 
c 
13 
c 
15 
c 
17 
c 
19 
MMS MMS 
F Compound 
c 2 
c 
4 
c 
6 
c 
8 
c 
10 
c 
12 
c 
14 
c 
16 
c 
18 
c 
20 
MMS MMS 
G Compound 
d 1 
d 
3 
d 
5 
d 
7 
d 
9 
d 
11 
d 
13 
d 
15 
d 
17 
d 
19 
DMSO DMSO 
H Compound 
d 2 
d 
4 
d 
6 
d 
8 
d 
10 
d 
12 
d 
14 
d 
16 
d 
18 
d 
20 
DMSO DMSO 
Figure 16. The plate map of the FC assay for HepG2/C3A cells. The concentration series of four 
compounds (a-d) were pipetted on one plate. The number refers to the rank of the concentration: 1 
meaning the top concentration and 20 the lowest concentration of the series. The controls were at 
columns 11 and 12.   
 
 
Table 7. The content of the complete labelling solution per one 96-well plate.  
Number 
of wells 
Volume of Nuclei 
release solution 
with counting 
beads 
Volume of 
DNA stain 
Volume of 
RNAse 
solution 
Volume of 
γH2Ax 
Alexa 
Fluor™ 647 
Volume of 
pH3 PE 
Volume of 
p53 FITC 
96 5.5 ml 137.5 μl 27.5 μl 27.5 μl 11.0 μl 27.5 μl 
 
4.7 Data analysis 
 
Since the purpose in this research was to find connections between the features of 
used markers, all the data was normalized based on the DMSO control to simplify the 
presentation and comparison. The exceptions were the γH2Ax and pH3 responder 
analyses that were built on the original data.  
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Responder analyses were developed for pH3 and γH2Ax markers in order to 
investigate how many percent of the cells with different treatments were positive for 
these markers. Since pH3 marker is binary, the cell would be pH3 positive if the 
member count is greater than zero. To exclude the possible false signals, the cell was 
categorized as pH3 positive when the member count was greater than two. The 
responder analysis for γH2Ax was based on the average intensity of the γH2Ax. The 
cell was categorized as positive if its average intensity was greater than the set limit. 
The limit was two standard deviations from the mean of the average intensity of the 
DMSO controls.  
 
The normalized data was used for calculating the lowest effective concentrations 
(LECs). In order to take only the actual events into account, the upper and lower limits 
of natural fluctuations were determined. Three standard deviations from the mean of 
the DMSO controls were chosen as limits. The decision was based on the 68-95-99.7 
rule of normal distribution, meaning that 99.7% of natural fluctuation in the data should 
be within the determined limits. LECs were the lowest concentrations that either 
exceeded the upper limit or went below the lower limit. 
 
The data gained from the HCA image analysis was analysed by Advanced cell 
classifier (ACC), a data analyser program (Piccinini et al., 2017). The cell images were 
used to train the program to classify the cells into created classes and the program 
based the classification on the similarity of the numeric data. The used classifier was 
MLP_Weka. The cells were classified into six classes: interphase, mitotic, rounded, 
stretched, damaged and unclassified cells. Percentage from all cells was calculated 
based on the output data of ACC. Validity of the classification was 75.5%. 
 
The statistical analysis was conducted by Excel, Spotfire and R. The significances of 
the differences were determined by Mann-Whitney U-test since not all of the data was 
normally distributed and only independent variables were compared. The levels of 
significance were set at p≤0.05 (*, significant), p≤0.01 (**, very significant) and 
p≤0.001 (***, extremely significant). 
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5. Results 
 
5.1 Setting up the HCA assay  
 
The first part of this research was to set up the HCA assay that was used for 
investigating the genotoxicity markers and cytoskeleton dynamics. The positive 
controls for pH3 and γH2Ax markers and for mitochondrial toxicity had to be selected 
and their suitable concentrations and incubation times had to be investigated for the 
HCA assay. Similarly, the specificity and proper function of antibodies had to be 
confirmed and the concentrations for both primary and secondary antibodies 
adjusted. The compounds used in the set up were the positive controls of the HCA 
assay and are presented in table 4. All the primary and secondary antibodies were 
tested with each compound treatment and blank control to examine their proper 
binding and specificity. Concentration series were used to set the suitable 
concentration for each antibody (table 8). The concentration of Hoechst and 
fluorochrome bound phalloidin, were not tested since their concentrations for HCA 
assay has previously been adjusted at Orion. The concentrations of antibodies were 
chosen based on the reasonable exposure time and signal-to-noise ratio of the 
images acquired by Cellomics. The concentrations of the positive controls were 
selected based on their γH2Ax and pH3 responses that needed to be distinguishable 
from the negative control. However, the concentrations had to be low enough to not 
to kill all the cells. 
 
 
 
Table 8. The concentration series used in the set-up for each antibody. The concentrations selected for 
the HCA assay are in red.  
Primary antibodies Secondary antibodies 
γH2Ax 
PA1-25001 
γH2Ax 
LF-PA0025 
pH3 Anti-β 
tubulin 
(m) 
Anti-β 
tubulin 
(r) 
Alexa 
546 
Alexa 
555 
Alexa 
633 
Alexa 
647 
1:500 1:400 1:1000 1:600 1:1000 1:1000 1:1000 1:1000 1:1000 
1:1000 1:800 1:2000 1:800 1:2000 1:2000 1:2000 1:2000 1:2000 
1:2000 1:1000 1:3000 1:1000 1:3000 1:3000 1:3000 1:3000 1:3000 
1:3000 1:2000 1:4000 1:2000 1:4000 1:4000 1:4000 1:4000 1:4000 
1:4000 1:3000 1:5000   1:5000   1:5000 
1:5000 1:4000 1:6000   1:6000   1:6000 
1:6000 1:5000 1:7000   1:7000   1:7000 
 1:6000 1:8000   1:8000   1:8000 
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5.2 Describing the features by the cell images 
 
To understand how the features that were measured in image analysis are linked to 
the appearance of the cells and markers, the data acquired from the image analysis 
and the cell images were compared. The γH2Ax and pH3 markers are presented in 
figure 17. γH2Ax, the marker for phosphorylated histone H2Ax, was seen as dots, 
each dot representing one DNA double strand break. The amount of γH2Ax correlated 
hence directly with the amount of DNA double strand breaks, either caused by 
topoisomerase II activity during interphase or by DNA damage. pH3, the marker for 
phosphorylated histone H3, was seen as ring-shaped and it was a binary marker, 
meaning that the cell is either pH3 positive (mitotic) or negative (non-mitotic).  
 
 
How the changes in parameters describing actin and tubulin were seen in the cell 
images, was investigated. Figure 18 shows how DMSO and metformin-treated cells 
differ from their actin and tubulin structure. It can be seen that both the data and image 
of metformin-treated cells looks very similar to the untreated cells. Since all of the data 
was normalized by the mean of DMSO, the averages of all the parameters of 
untreated cells were 100.  
 
Figure 17. Overlays of 20x confocal images of HepG2/C3A cells taken with Opera Phenix HCS system 
(PerkinElmer, USA). The nucleus is seen in red, tubulin in green and actin in blue. A) Cells treated with 
MMS. The arrows point γH2Ax positive cells. γH2Ax can be seen as dots within the nucleus. B) Cells 
treated with paclitaxel. The arrows point pH3 positive (mitotic) cells. pH3 marker was usually seen as 
ring-shaped.   
50 µm 50 µm 
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The data from nefazodone and paclitaxel-treated cells have been illustrated in figure 
19. Nefazodone and paclitaxel increased the intensity of the tubulin and actin and 
decrease the alignment 1 parameters. Despite the similar behaviour of the 
parameters, the images of the cells look different: nefazodone-treated cells have 
elongated tubulin whereas the tubulin of paclitaxel-treated cells is brush-shaped. 
 
Figure 18. A) The tubulin and actin intensity and fiber alignment of metformin-treated cells in each tested 
concentration. The parameters did not differ from the untreated cells. The vertical line demonstrates the 
concentration of the metformin-treatment of the cells shown in figure C. B) 20x magnification of the 
normal, untreated HepG2/C3A cells. C) 20x image of metformin-treated cells. In images, the nucleus is 
seen in red, tubulin in green and actin in blue. The images were taken with Cellomics.   
50 µm 50 µm 
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Figure 19. A) The tubulin and actin intensity and fiber alignment of nefazodone-treated cells in each 
concentration. The intensity of both actin and tubulin increased with the increasing concentration whereas 
the alignment parameters decreased. The vertical line represents the concentration of the nefazodone-
treatment of the cells shown in figure B. B) 20x magnification of nefazodone-treated cells. The cells 
seemed elongated and it can be seen that the tubulin fibers were organized and aligned parallel. C) The 
intensity and fiber alignment data of actin and tubulin for paclitaxel-treated cells. The intensity parameters 
of paclitaxel are increased compared to DMSO level and the fiber alignment parameters are decreased, 
indicating the organization of the fibers. The vertical line demonstrates the concentration of paclitaxel-
treatment of cells shown in figure D. D) 20x magnification of paclitaxel-treated cells. It can be seen that 
tubulin had a brush-shaped organization and some of the cells have rounded. In the images, the nucleus 
is seen in red, tubulin in green and actin in blue. The images were taken with Cellomics.    
50 µm 
50 µm 
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5.3 Selection of parameters for the data analysis 
 
Several features were measured from each channel in the image analysis (table 6). 
Since many of these features behaved very similarly, one parameter per channel was 
selected for the comparison. The parameters for tubulin are illustrated in figure 20. All 
five parameters seemed to correlate with each other. The fiber alignment and intensity 
parameters were preferred since they described the organization of the tubulin: 
increased intensity and decreased variation of the fiber alignment (Fiber alignment 1 
feature) indicated the condensation of the tubulin fibers. The intensity of tubulin was 
chosen for the comparison since it was sensitive and gave response with each 
compound treatment. The response was also strong and therefore easy to detect.   
 
 
Similarly, the parameters for actin are shown in figure 21. The changes in all of the 
three parameters appeared to happen simultaneously. Intensity of actin was chosen 
for the comparison since it seemed to give a strong response and react sensitively 
e.g. to toxicity.  
 
 
Figure 20. The measured tubulin parameters of the cells treated with different concentrations of 
fluoxetine, levosimendan or tolcapone at time point 24 h. It is seen that the parameters correlated with 
each other.  
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Features, such as nucleus area and intensity, described the condensation of 
chromatins. These two parameters seemed to have negative association (figure 22). 
The area of the nucleus was chosen for the comparison since it is the more descriptive 
of the two parameters.  
 
Figure 21. The measured actin parameters for the cells treated with fluoxetine, levosimendan or 
tolcapone at different concentrations. The time point was 24 h. It can be seen that all the parameters that 
gave responses reacted at the same concentrations.   
Figure 22. The measured nucleus parameters for cells treated with fluoxetine, levosimendan or tolcapone 
at different concentrations and at time point 24 h. It can be seen that the two parameters correlate with 
each other. 
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5.4 LECs of parameters 
 
To investigate the order of the events and to estimate if the events occur because of 
the reduced ATP production, the LECs were determined for each selected parameter. 
The average intensity of nucleus and fiber alignment 1 features of tubulin and actin 
were also included in the LEC comparison to ensure the selection of the parameters 
described in previous chapter was well founded. The purpose was to find out which 
parameters reacted first to the compound treatment in order to evaluate the possible 
causality of the events. The determined LECs were also compared with the lowest 
concentrations causing mitochondrial toxicity (LEC of Seahorse oxygen consumption) 
to estimate whether ATP depletion is the cause of the other events. The 
concentrations for mitochondrial toxicity have been determined previously at Orion. 
LECs of different features at the time point 24 h are presented in table 9.      
 
Table 9. The LECs of selected features at time point 24 h.  
 
Seahorse assay has not been performed for paclitaxel and staurosporine and the 
concentration ranges have not been suitable for LEC determination for metformin, 
rotenone, buspirone, amiodarone and oligomycin. Mitochondrial toxicity of these 
compounds cannot thus be compared with cytoskeleton and DNA damage features 
but it can be seen that the concentrations are not divergent. Table 9 shows that 
mitochondrial toxicity is usually seen at lower concentrations than the other 
parameters. Exceptions are phenformin that seems to give γH2Ax response at its 
lowest concentration and fluoxetine that appears to affect tubulin before the 
mitochondria.  
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The order of the events differs considerably depending on the compound. Metformin 
treatment does not affect any of the measured features at all tested concentrations 
and nimesulide, buspirone and 2,4-dinitrophenol seem to have an effect only at the 
highest concentration. On the contrary, paclitaxel appears to affect all the features 
simultaneously at its lowest concentrations. To summarize the behaviour of different 
compounds and to examine the possible similarities, a hierarchical clustering based 
on the LECs and Euclidean distance was performed. Since the concentration series 
vary with different compounds, the rank of the LEC was used instead of actual 
concentration, meaning that the lowest concentration was given a value 1, the second 
lowest a value 2, etc. The clustering is represented in figure 23.  
 
The clustering separated paclitaxel and staurosporine from other compounds and 
they appeared to trigger the strongest response to the parameters. They were 
clustered next to oligomycin and rotenone and all of the four compounds appeared to 
affect especially the cell count, nucleus area and γH2Ax parameters. The weakest 
response was given by metformin but the compounds that also acted as negative 
control, buspirone and entacapone, were not among the weakest compounds. 
However, all of them were clustered together to a group that showed least effects. 
Figure 23. The clustering based on the ranking number of the LECs. The averages of both time points, 
6 h and 24 h, were used in the clustering and it did not consider the direction of the response, i.e. if the 
LEC exceeded or went below the set limits. The order of the compounds depended on the similarity of 
the behavior of the compounds and it was affected by the strength of the response. The smallest ranking 
number is shown in dark red and the highest dark green.  
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Cytoskeleton was affected by paclitaxel and staurosporine but also by tolcapone, 
fluoxetine, amiodarone, nefazodone and troglitazone that were all at the same cluster. 
The mechanisms behind the toxicity of the compounds were not distinguished from 
the clustering, i.e. the compounds that disturb the ATP production the same way were 
not clustered exclusively together.   
 
5.5 Toxicity of the compounds 
 
The toxicity of the compounds was investigated by measuring the cell count and 
observing the possible decreasing dose response. If the cell count drops below 50%, 
it is a sign of a clear toxicity of the compound since it indicates that the cell proliferation 
has arrested and the cells have started dying immediately after the addition of the 
compound. The toxicity of the compounds was examined to evaluate if the 
concentration series have been optimal. The substantial decrease of the cell 
population due to the toxicity may cause an error to the results and, hence, it must be 
taken into consideration when interpreting the results. The cell counts for controls are 
presented in figure 24 and for each concentration of each compound in figure 25. 
 
It can be seen from figure 25 that most of the compounds had a dose response in 
their cell count and the reduction was faster in 24 h time point than in 6 h. The cell 
count after the treatment by amiodarone, buspirone and metformin was not affected. 
Fluoxetine was strongly toxic in high concentrations as seen in 6 h and 24 h time 
points. The cell count of levosimendan, staurosporine and tolcapone was decreased 
to 50% in 24 h time point. The cells treated with oligomycin, paclitaxel, rotenone and 
staurosporine behaved very differently than the rest of the compounds. There was 
only a slight dose response and it seems that the decrease in the cell count stopped 
above 50% and remained constant despite the increasing concentration. Figure 24 
shows that CCCP and MMS were also toxic at 24 h time point. 
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Figure 24. The cell counts of the controls as a percent of DMSO control. It is seen that the count of cells 
treated with positive controls was always lower than the count of untreated cells. MMS and CCCP were 
toxic to cells at time point 24 h since the cell count decreased below 50%.  
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Figure 25. The cell counts after the treatment with the compounds. Fluoxetine, levosimendan, tolcapone 
and staurosporine showed toxicity at time point 24 h since the cell count decreased to or below 50%. 
Oligomycin, paclitaxel, rotenone and staurosporine appeared to have only a minor dose response in the 
cell count.    
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5.6 Responder analysis for pH3 and γH2Ax 
 
The purpose of the responder analyses was to investigate if mitochondrial toxins 
cause increase of genotoxic markers. The amount of pH3 and γH2Ax positive cells 
was interpreted to be increased when it exceeded the average level of DMSO 
controls. The correlation between γH2Ax and pH3 was also examined. Altogether, the 
results of pH3 and γH2Ax responder analyses for each compound and time point are 
found in appendix A. 
 
All the compounds, excluding metformin, seemed to increase the amount of γH2Ax 
responder cells at 24 h time point. Only paclitaxel, levosimendan and tolcapone 
treatments seemed to trigger the pH3 response but the quantity of pH3 responders 
was often decreased due to compound treatment. When pH3 and γH2Ax responses 
were compared, it was noticed that most of the compounds behaved similarly: the 
number of the γH2Ax responder cells was increased while the amount of pH3 positive 
cells was decreased with the increasing concentration. Figure 26 represents 
entacapone at time point 24 h as an example of this type of behaviour. The pH3 
response of entacapone-treated cells was not triggered but the quantity of pH3 
positive cells seemed to decrease dose dependently. The pH3 response was 
significantly different between entacapone-treated and DMSO-treated cells since 
concentration 33.33 µM (p<0.01). The amount of γH2Ax positive cells treated with 
entacapone increased dose dependently and differed significantly from DMSO level 
since concentration 100 µM (p<0.05). The significance levels of the presented 
concentrations are shown in figure 26. 
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The results of levosimendan- and tolcapone-treated cells in time points 6 h and 24 h, 
respectively, were deviant since both the amount of γH2Ax and pH3 positive cells 
appeared to increase with the increasing concentration. The four highest 
concentrations of levosimendan at time point 6 h are shown in figure 27. It can be 
seen that the number of pH3 positive cells is increasing until it is reduced at 
concentration 200 µM. The pH3 response of levosimendan was significantly different 
from DMSO control since concentration 33.33 µM (p<0.01). The γH2Ax response 
differed significantly between DMSO control and levosimendan-treatment only at 
concentration 200 µM (p<0.05). 
 
 
Figure 26. The γH2Ax and pH3 responders of the three highest concentrations of entacapone. The 
responders of entacapone and DMSO are shown on primary y-axis and the positive controls on the 
secondary y-axis. The significances of differences to DMSO are shown in asterisks: (p>0.05 n.s., p≤0.05 
*, p≤0.01 **, p≤0.001 ***) The error bars demonstrate the standard error. A) the amount of γH2Ax positive 
cell after entacapone treatment increased dose dependently. B) There was a decreasing dose response 
in the pH3 marker of entacapone-treated cells. The pH3 response of entacapone did not exceed the 
DMSO level at any concentration and the difference to DMSO was significant since concentration 33.33 
µM. 
* 
* 
n.s. 
** 
*** 
*** 
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Paclitaxel-treatment was distinguishable in responder analyses since it increased the 
amount of both γH2Ax and pH3 positive cells substantially. The differences between 
DMSO level and γH2Ax and pH3 responses after paclitaxel treatment since the lowest 
concentration (0.019 µM) were statistically extremely significant (p<0.001). The 
responders at the four lowest concentrations of paclitaxel at time point 24 h are 
illustrated in figure 29. 
Figure 27. The γH2Ax and pH3 responders at four highest concentrations of levosimendan and DMSO 
are shown on the primary y-axis and the positive controls on the secondary y-axis. The significances of 
differences to DMSO are shown as asterisks (p>0.05 n.s., p≤0.05 *, p≤0.01 **, p≤0.001 ***). The error 
bars refer to standard error. A) the quantity of γH2Ax positive cells increased dose dependently. B) There 
was an increase for pH3 marker until the collapse at concentration 200 µM. 
* 
n.s 
*** 
n.s. 
n.s. 
* ** 
*** 
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5.7 Nucleus area and responder analyses 
 
The nucleus area of the cells was compared with the γH2Ax and pH3 responder data 
to investigate the mechanism behind the changes of pH3 and γH2Ax responses. The 
purpose was to observe possible correlations between these parameters. The 
illustrations of this data comparison altogether can be found in appendix B.  
 
Compounds, such as amiodarone, buspirone, fluoxetine, staurosporine and 
nefazodone appeared to decrease the nucleus area dose dependently. These 
compounds also showed dose response in γH2Ax and thus it seemed that the nucleus 
area and γH2Ax response had negative correlation. pH3 response did not seem to 
correlate with nucleus area. Amiodarone at time point 24 h is illustrated in figure 30 
as an example. The nucleus area of amiodarone-treated cells differed from DMSO 
level at all presented concentrations while the γH2Ax response was different between 
Figure 29. The γH2Ax and pH3 responders at the four lowest concentrations of paclitaxel at time point 
24 h. Paclitaxel and DMSO are show on primary y-axis and the positive controls on secondary y-axis. . 
The significances of differences to DMSO are shown as asterisks (p≤0.001 ***). The error bars 
demonstrate the standard error. A) the number of γH2Ax positive cells after paclitaxel treatment 
increased dose dependently and the difference to DMSO level was statistically significant already at the 
lowest concentration (0.019 µM). B) The increase of pH3 positive cells was statistically significant already 
at the lowest concentration (0.019 µM) of paclitaxel. The increase was dose dependent.  
*** 
*** 
*** 
*** 
*** 
*** 
*** *** 
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amiodarone and DMSO since concentration 10 µM. The changes between 
concentrations 10 µM and 20 µM was significant in nucleus area (p<0.01) and γH2Ax 
response (p<0.05).  
 
 
 
Compounds such as 2,4-dinitrophenol, entacapone, nimesulide, levosimendan and 
tolcapone, which are all uncouplers, appeared to increase both nucleus area and the 
amount of γH2Ax positive cells dose dependently. pH3 response did not appear to 
correlate with the nucleus area. Nucleus area and γH2Ax and pH3 responses of 
nimesulide-treated cells are illustrated in figure 31 as an example. The nucleus area 
and γH2Ax response of nimesulide-treated cells were significantly different to DMSO 
level at concentration 200 µM (p<0.001 and p<0.05, respectively). There was no 
statistically significant difference between pH3 responses of nimesulide-treated cells 
and DMSO level. 
 
The rest of the compounds did not seem to cause increasing or decreasing trend in 
nucleus area. Nucleus area was elevated in the cells treated with oligomycin and 
rotenone, while paclitaxel-treated cells had reduced nuclei.  
Figure 30. The nucleus area, γH2Ax and pH3 responders of the cells treated with amiodarone at the 
three highest concentrations and with DMSO. The nucleus area is shown on the primary y-axis and the 
responders on secondary y-axis. The significances of differences to DMSO are shown as asterisks 
(p>0.05 n.s., p≤0.05 *, p≤0.01 **, p≤0.001 ***). The error bars demonstrate the standard error. The 
nucleus area decreased and the number of γH2Ax positive cells increased with the increasing 
concentration. There was no dose response in pH3. The change between concentrations 10 µM and 20 
µM was very significant in nucleus area and significant in γH2Ax response.  
n.s. 
* 
*** 
n.s. 
*** ** 
* 
*** 
*** 
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5.8 Cytoskeleton and responder analyses 
 
The actin and tubulin intensity was compared with γH2Ax and pH3 responder data to 
examine if the changes in the dynamics of cytoskeleton predicted or correlated with 
the genotoxic markers. The purpose was to estimate whether the ATP depletion might 
lead to DNA damage via changed dynamics of cytoskeleton. Altogether, the 
illustrations of this data are found in appendix C.  
 
The compounds seemed to cause similar reactions to both actin and tubulin, 
excluding paclitaxel and staurosporine that appeared to affect tubulin more strongly 
than actin. Most of the compounds seemed to cause increase of tubulin and actin 
intensity together with triggered γH2Ax response at higher concentrations. However, 
which of the events occurred first, depended on the compound. The strength of the 
response of tubulin, actin and γH2Ax also appeared to have a possible association. 
The intensity of actin and tubulin and pH3 response did not have a visible association, 
with the exception of the compounds that caused negative correlation between γH2Ax 
and pH3 responses and paclitaxel. Figure 32 represents 2,4-dinitrophenol as an 
example. It shows that actin and tubulin intensity behaved identically and began to 
increase at the concentration 100 µM. The actin and tubulin intensity differed 
Figure 31. The nucleus area, γH2Ax and pH3 responses of DMSO-treated cells and cells treated with 
nimesulide at three highest concentrations at time point 24 h. Nucleus area is shown on primary y-axis 
and responders on secondary y-axis. The significances of differences to DMSO are shown as asterisks 
(p>0.05 n.s., p≤0.05 *, p≤0.01 **, p≤0.001 ***). The error bars demonstrate the standard error. The 
nucleus area and the number of γH2Ax positive cells increased with the increasing nimesulide 
concentration but differed from DMSO level only at the highest concentration. The amount of pH3 
responders decreased with increasing nimesulide concentration but the reduction was not statistically 
significant.   
n.s. 
n.s. 
n.s. 
n.s. 
n.s. n.s. 
*** 
n.s. 
* 
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significantly between DMSO level and 2,4-dinitrophenol-treatment at concentrations 
100 µM (p<0.01) and 200 µM (p<0.001). The increase of tubulin and actin intensities 
between these concentrations was also statistically significant (p<0.01). The increase 
of γH2Ax positive cells followed behind and began at concentration 200 µM which 
differed from DMSO level very significantly (p<0.01). The change in the γH2Ax 
response after 2,4-dinitrophenol-treatment was also significant between 
concentrations 100 µM and 200 µM (p<0.05).    
 
Entacapone, nimesulide and phenformin treatments did not appear to cause a similar 
association between actin and tubulin intensities and γH2Ax response. For example, 
entacapone increased the number of γH2Ax positive cells dose dependently. 
However, the actin and tubulin intensities did not increase but seemed to fluctuate 
below the DMSO level. As explained in chapter 5.6, γH2Ax response of entacapone 
and DMSO differed significantly at concentrations 100 µM and 200 µM. The tubulin 
and actin intensities did not increase significantly in these concentrations. The actin 
and tubulin intensities and responder analyses of entacapone are illustrated in figure 
33.  
Figure 32. Tubulin and actin intensity and γH2Ax and pH3 responses at the three highest concentration 
of 2,4-dinitrophenol and DMSO at time point 24 h. The responder analyses are shown on the primary y-
axis and the intensities on the secondary y-axis. The pH3 response of 2,4-dinitrophenol decreased dose 
dependently and differed from pH3 response of DMSO significantly since concentration 100 µM (p<0.01). 
γH2Ax response of 2,4-dinitrophenol began to increase and differed significantly from DMSO at 
concentration 200 µM (p<0.01). Tubulin and actin intensities behaved almost identically and they differed 
significantly between 2,4-dinitrophenol and DMSO since concentration 100 µM (p<0.01). The increase 
of actin and tubulin intensities began one concentration before γH2Ax response.  
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5.9 Analysis by Advanced cell classifier (ACC) 
 
The data acquired from the HCA image analysis was analysed by ACC to investigate 
if certain types of cells were predominant after the compound treatment. Table 10 
shows the distribution of the cells at time point 24 h for the top concentrations of the 
compounds. Since the top concentrations of staurosporine, fluoxetine, levosimendan 
and tolcapone lowered the cell count, as described in chapter 5.5, their highest non-
toxic concentration was chosen for the presentation. 
 
Figure 33. Tubulin and actin intensity and γH2Ax and pH3 responses after the treatment with entacapone 
at the three highest concentrations and DMSO at time point 24 h. The responder analyses are shown on 
the primary y-axis and the intensities on the secondary y-axis. The γH2Ax responses were significantly 
different from the DMSO level at concentrations 100 µM and 200 µM. The increase of tubulin and actin 
intensities were not significant (p>0.05). The p-values for γH2Ax and pH3 are presented in figure 26.   
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The table 10 shows that the percentages in each class appeared to vary evidently. 
Excluding the cells treated with amiodarone, nefazodone, CCCP and MMS, most of 
the cells seemed to be in interphase. The cells treated with tubulin stabilizers 
paclitaxel and griseofulvin had the highest percentage of mitotic cells. CCCP and 
MMS seemed to affect the cell shape since they caused both the rounding and 
stretching of the cells. According to this analysis, nefazodone and MMS caused 
distinctly more damage to the cells than the other compounds.    
 
5.10 Comparing HCA data with flow cytometry data 
 
Flow cytometry DNA damage assay was performed with both HepG2/C3A and TK6 
cells. DNA damage assays are conventionally performed by flow cytometry with TK6 
cells at Orion, and the purpose was to compare TK6 data with HepG2/C3A flow 
cytometry data. The flow cytometry DNA damage assay with HepG2/C3A cells was 
performed to have a comparison to γH2Ax and pH3 data gained from HCA. Even 
though the effects of a given concentrations cannot be compared between TK6 and 
Table 10. The classification of the cells by ACC at time point 24 h. The percentage of each class is shown 
for the given concentration. The red color refers to highest percentages and blue to lowest, except for 
the classes interphase cells and mitotic cells where the red demonstrates the lowest and blue the highest 
percentage.   
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HepG2/C3A cells due to the differences of the two cell lines, it was possible to observe 
the similarities of the reactions to the compounds. Since γH2Ax and pH3 responses 
were the common parameters of FC and HCA assays, only those were compared. In 
FC assay, the responses were calculated as folds and no responder analysis was 
conducted.  
 
The FC and HCA data of entacapone is illustrated in figure 34. It is seen that the 
number of γH2Ax positive cells increased dose dependently in both cell lines and 
assays. The increase started at lower concentration in TK6 cells than in HepG2/C3A 
cells. pH3 response had also similarities in both cell lines and assays. The number of 
pH3 positive cells fluctuated at lower concentrations and decreased at higher 
concentrations in TK6 cells and in HepG2/C3A cells of HCA assay. pH3 positive 
HepG2/C3A cells did not have similar visible decrease in FC assay but otherwise their 
fluctuation resembled that of TK6 cells. The pH3 response was lost at lower 
concentration in TK6 cells than in HepG2/C3A cells.     
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Figure 34. A) γH2Ax and pH3 folds of entacapone-treated TK6 cells determined by FC. γH2Ax fold 
increased dose dependently while pH3 fold fluctuated. Both of the folds decreased at highest 
concentrations. B) FC data of γH2Ax and pH3 folds of entacapone-treated HepG2/C3A cells. γH2Ax fold 
behaved similarly than in TK6 cells but the increase began at higher concentration. pH3 fold fluctuated 
similarly than in TK6 cells but the response was not lost at high concentrations. C) γH2Ax and pH3 
responses of entacapone-treated HepG2/C3A cells determined by HCA. The number of γH2Ax positive 
cells increased dose dependently. The amount of pH3 positive cells fluctuated at lower concentrations 
but began to decrease dose dependently above a concentration of 33.333 µM.  
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6. Discussion 
 
6.1 Evaluating the toxicity of the compounds 
 
Before interpreting the other results, the toxicity of the compounds had to be 
investigated to evaluate both the optimality of the concentration series used in the 
assays and the possibility of an error caused by the reduced cell population. The cell 
count after the compound treatment was examined to evaluate the toxicity of the 
compounds. It was noticed that some compounds, such as amiodarone, metformin 
and buspirone, did not affect the cell count. This may have been due to the too low 
top concentrations of these compounds. This had to be taken into consideration when 
observing the behaviour of other parameters in these compounds since it is possible 
that some of the effects are not visible when the concentration is too low. Oligomycin, 
staurosporine and rotenone had a cell count lowering effect at the lowest 
concentration of the series at time point 24 h. This indicates that the lowest 
concentration of these compounds was not low enough. This might cause error when 
estimating the order of the events since some of the effects may have been visible 
only at the lower concentrations of the toxins. Fluoxetine, levosimendan and 
tolcapone reduced the cell count near to or below 50%. This had to be taken into 
consideration when interpreting the other results since the possibility of an error 
increases when the cell population caused by the toxicity of the compounds reduces 
considerably.   
 
It was noticed that oligomycin, staurosporine, rotenone and paclitaxel did not cause 
dose dependent decrease in cell count but the cell count seemed to stabilize into 
constant level. This was expected from paclitaxel that is known to arrest the mitosis 
during metaphase (L. Yang et al., 2010). The cells did not proliferate but the toxic 
effect of paclitaxel was not strong enough to induce cell death. In addition to 
mitochondrial effect, staurosporine is known to inhibit the Cdk1, which is a component 
of the cell cycle checkpoint regulation (Vermeulen et al., 2003). This mechanism may 
explain the arrest of cell proliferation seen in the cell count data of staurosporine. As 
known complex inhibitors (Heinz et al., 2017; Jonckheere et al., 2012), rotenone and 
oligomycin arrested the cell cycle possibly due to the ATP depletion they cause in the 
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cell. Upon inefficient oxidative phosphorylation, the cells do not have enough energy 
for the proliferation and they may exit the cell cycle to the G0 resting phase. 
 
6.2 The order of the events and the similarities of the compounds 
 
In this research, in addition to cell count, several parameters were determined to 
assess the effect of the compounds on the cells. Tubulin and actin require ATP to 
function and, hence, the possible changes in their dynamics after treatment with 
mitochondrial toxins were evaluated. The purpose of this research was to find out if 
mitochondrial toxins induce DNA damage and, thus, the DNA damage markers, pH3 
and γH2Ax, were examined.  
 
The LECs of the compounds for each chosen parameter were determined to 
investigate the order of the events caused by the compound treatment. The purpose 
was to investigate whether ATP depletion might cause increased number of pH3 and 
γH2Ax positive cells and if the effect might be due to the changed dynamics of 
cytoskeleton. Clustering was conducted based on the LECs to find similarities 
between the behaviour of different compounds. The LECs were compared with the 
lowest concentrations causing mitochondrial toxicity and it was noticed that, except 
for phenformin and fluoxetine, the mitochondrial toxicity was seen at lower 
concentrations than the other parameters. This supports the hypothesis of the thesis 
that the DNA damage and alterations in cytoskeleton dynamics would be caused by 
the mitochondrial dysfunction. However, the determination of the toxic concentrations 
to mitochondria was conducted in the absence of glucose whereas the other 
parameters were measured to cells grown in glucose medium. The presence of 
glucose enables glycolysis that compensates the insufficient function of oxidative 
phosphorylation. It is possible that without glycolysis the LECs for the HCA 
parameters would have been lower.  
 
The order of the events varied depending on the compound. To support the 
hypothesis, the LECs for tubulin and actin parameters should have been lower than 
for γH2Ax and pH3 parameters but higher than for mitochondrial toxicity. Troglitazone, 
nefazodone and staurosporine were the only compounds that gave this type of result. 
Many LECs were determined to be higher than the top concentration tested in this 
research. This also confirms that the concentration series were not optimal for all 
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compounds as was suggested in chapter 6.1. The limits for LEC determination (Mean 
of DMSO ± 3SD) may have also been too exclusive. Some parameters might also 
have naturally larger deviation than others and therefore the threshold of LECs is 
higher for those parameters. This may cause error when comparing the different 
parameters and observing the order of the events. 
 
The clustering analysis separated paclitaxel and staurosporine from the rest of the 
compounds. This was predictable since, as described in previous chapter (6.1), 
staurosporine and paclitaxel have direct effects on cell cycle and may arrest the cycle 
completely. Oligomycin and rotenone were clustered together, next to staurosporine. 
This supports the mechanism suggested in previous chapter (6.1) that the ATP 
depletion caused by them would arrest the cell cycle and hence, oligomycin and 
rotenone would cluster close to staurosporine and paclitaxel. However, unlike 
paclitaxel and staurosporine, oligomycin and rotenone did not seem to affect tubulin 
or actin dynamics. This difference can possibly be explained by the different 
mechanisms of these toxins. Paclitaxel is a tubulin stabilizer and may arrest the cell 
cycle during metaphase (L. Yang et al., 2010). Hence, it is expected that paclitaxel 
increases the proportion of polymerized tubulin which is prevalent in metaphase. 
Staurosporine inhibits Cdk1 which participates cell cycle regulation in restriction point 
(Vermeulen et al., 2003). Thus, it can be assumed that the cell cycle arrest would take 
place in the beginning of the cell cycle and the depolymerized tubulin would be 
predominant. Energy shortage, which may be the reason for the possible cell cycle 
arrest caused by rotenone and oligomycin, does not arrest the cell cycle as specifically 
in certain phase as tubulin stabilization or Cdk1 inhibition. Thus, the cell cycle of an 
individual cell may be arrested at any checkpoint and the arrest is not seen in tubulin 
dynamics of the rotenone or oligomycin treated cell population. 
 
It would have been expected that compounds with similar mechanisms had clustered 
closer together. The suboptimal concentration series may have caused error to the 
clustering analysis. Also, since the clustering used averages from both time points 
and the number of events at 6 h was clearly lower than at 24 h, it is possible that some 
of the effects were not seen in it. 
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6.3 The correlation of pH3 and γH2Ax responses 
 
One part of the research question was whether mitochondrial toxins cause DNA 
damage. This was investigated by observing the increase of mitotic marker, pH3 and 
DNA double strand break marker, γH2Ax. The developed responder analyses 
seemed to be functional since the positive controls caused the strongest responses 
as was expected. However, since the cells were categorized binary as positive or 
negative at both responder analyses, substantial reduction in cell count causes error 
in percentage. This was taken into consideration when interpreting the results. The 
comparison of γH2Ax and pH3 responses had to be treated with caution since the two 
markers were applied to the different plates. Hence, the cell population is not identical 
even though the treatment of the cells has been similar.  
 
It was noticed that most of the compounds increased the number of γH2Ax positive 
cells and decreased the amount of pH3 positive cells dose dependently. This indicates 
that these compounds did affect the DNA damage markers. The negative correlation 
of pH3 and γH2Ax was expected since normally functioning cells should not enter 
mitosis if there are DNA double strand breaks in chromosomes. This expected result 
indicates that the mitochondrial toxins did not cause defects in cell cycle checkpoint 
system. This suggests that despite the ATP depletion caused by the mitochondrial 
toxins, the energy production of the cells was adequate to maintain the cell cycle 
regulation. Since the responder analysis for γH2Ax was developed to exclude the 
DNA double strand breaks that are caused by the topoisomerase II during DNA 
replication in interphase, the increase of γH2Ax responder cells suggests that the 
compounds induced the formation of DNA double strand breaks rather than arrested 
the cell cycle during interphase. However, if the thresholds for the γH2Ax responder 
analysis have been suboptimal, it is possible that the triggered γH2Ax response was 
due to the predominance of interphase cells. The increased γH2Ax response may 
also indicate that the DNA repair system was interfered due to the ATP shortage and 
did not work sufficiently. 
 
Levosimendan at time point 6 h and tolcapone at time point 24 h increased both the 
number of pH3 and γH2Ax positive cells dose dependently. The behaviour of 
tolcapone can possibly be explained by the reduced cell count since the pH3 response 
was elevated only at top concentration, which was determined as toxic based on the 
cell count data. Levosimendan was not toxic at time point 6 h and pH3 response was 
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significantly increased at several concentrations. However, the increase of γH2Ax 
response was significant only at the top concentration where pH3 response was 
dropped. Thus, the γH2Ax and pH3 responses were not elevated simultaneously. 
Since none of the compounds, excluding paclitaxel, increased the amount of pH3 
responder cells dose dependently, it is probable that the induction of γH2Ax 
responses was not due to stabilization or destabilization of tubulin. This means also 
that it is improbable that the energy shortage would lead to DNA damage because 
there would not be enough ATP for tubulin to depolymerize. Tubulin requires ATP for 
depolymerization as was explained in chapter 2.3 (Spurck & Pickett-Heaps, 1987). 
Paclitaxel is expected to trigger pH3 and γH2Ax responses simultaneously since as 
a tubulin stabilizer it disturbs the segregation of sister chromatids and may not only 
delay or arrest the cell cycle during mitosis but also tear the chromatids, which leads 
to DNA damage (Field et al., 2013). 
 
6.4 The mechanisms behind the pH3 and γH2Ax responses 
 
The results of γH2Ax and pH3 responder analyses were compared with nucleus area 
and tubulin and actin intensity to investigate the possible mechanisms behind the 
significant changes in DNA damage markers. The increase in the nucleus area 
indicates the decondensation of the chromatin, which may be caused by the DNA 
strand breaks. Nucleus area may also be larger after the DNA replication since the 
amount of chromatin is doubled. The decrease of the nucleus area refers to 
condensation of the chromatins, which is a sign of either mitosis or apoptosis. 
Amiodarone, buspirone, fluoxetine, staurosporine and nefazodone that are all 
complex inhibitors, decreased nucleus area and increased the number of γH2Ax 
positive cells dose dependently. This negative association indicates that the γH2Ax is 
caused by the cytotoxic effect since the cells are probably dead. The reduced nucleus 
area due to mitosis should have been observed also as an induction of pH3 response, 
which was not seen.  
 
Entacapone, 2,4-dinitrophenol, nimesulide, levosimendan and tolcapone that are all 
uncouplers, increased both the nucleus area and the amount of γH2Ax responder 
cells. The positive association indicates that the increased quantity of γH2Ax positive 
cells was not a consequence of cell death but due to some other mechanism. 
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Simultaneous increase in nucleus area and in γH2Ax marker would be expected also 
when the cell cycle is arrested during interphase after the DNA replication. It is 
possible that the γH2Ax responder analysis has not been exclusive enough to limit all 
the naturally caused DNA double strand breaks and the uncouplers would cause 
triggered γH2Ax response due to the interphase arrest caused by the ATP shortage. 
However, the cell counts of uncouplers did not indicate a cell cycle arrest. It is rational 
that the complex inhibitors induced cell death whereas uncouplers did not appear to 
do that, since complex inhibition in mitochondria prevents the ATP production 
completely while uncoupling merely reduces it.  
 
The increase of tubulin and actin intensities indicates the condensation, i.e. 
polymerization, of the microtubules and microfilaments, respectively. Especially the 
polymerization of tubulin suggests that the cells are in mitosis. As was described in 
chapter 2.3, actin polymerization and tubulin depolymerization requires ATP and, 
thus, ATP depletion might result in tubulin stabilization or actin disruption (Heng & 
Koh, 2010; Spurck & Pickett-Heaps, 1987). Most of the compounds appeared to affect 
both tubulin and actin and there seemed to be positive association between 
cytoskeleton intensities and triggered γH2Ax response. However, the causal 
connection between cytoskeleton markers and γH2Ax response could not be verified, 
since it seemed that all the events started at the same concentration. The number of 
pH3 positive cells was not increased and hence the increase in tubulin intensity was 
probably not due to stabilization of tubulin in mitosis. The increasing number of γH2Ax 
positive cells can also be caused by the cell cycle arrest in S phase that could occur 
due to energy shortage. However, if the cells do not enter mitosis, it would be 
expected that the tubulin intensity would not increase as it did.  
 
The connection between cytoskeleton and DNA damage has been previously studied. 
Since actin participates in DNA repair system, it should have a correlation with γH2Ax. 
This correlation has been confirmed by several studies that have shown that the 
inhibition of actin polymerization results in DNA damage and that DNA damage 
induces the actin polymerization (Andrin et al., 2012; Belin et al., 2015; Shin et al., 
2011). Also, tubulin dynamics and DNA damage has been associated with each other 
but based on studies by Porter & Lee (2001) and Schofield & Bernard (2013) DNA 
damage seems to induce the tubulin polymerization rather than vice versa. The 
previous studies would suggest that the increase of tubulin and actin intensity 
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simultaneously with triggered γH2Ax response that was seen in this research would 
be a consequence of DNA damage rather than because of ATP depletion.  
 
Compounds such as entacapone, phenformin and nimesulide showed either negative 
association or no association at all between γH2Ax marker and cytoskeleton 
intensities. This does not support the suggestion that the polymerization of actin and 
tubulin was due to DNA damage but rather that the γH2Ax response and changes in 
cytoskeleton dynamics would be independent events caused by the ATP depletion or 
cytotoxicity. However, these two suggestions are not exclusive since the mechanism 
behind the disruption in cytoskeleton dynamics and DNA damage may vary 
depending on the compound.  
 
Since the tested compounds included only mitochondrial toxins, it is difficult to 
estimate if the changes in cytoskeleton dynamics were due to ATP depletion or 
cytotoxic effect. Previous studies have suggested that ATP depletion would increase 
actin aggregation but decrease actin polymerization (Atkinson et al., 2004; Bacallao 
et al., 1994; Ozawa et al., 2015). The intensity of the actin marker is probably not a 
suitable parameter to estimate whether actin is aggregated or polymerized since both 
aggregation and polymerization would increase the intensity compared to globular 
actin. The association between tubulin and ATP depletion has not been as 
unanimous. Bacallao et al. (1994) did not find any difference in the behaviour of 
tubulin after ATP depletion while Rand et al. (2014) suggested that ATP depletion 
would stabilize microtubules. Hence, it is possible that ATP depletion could result in 
increased tubulin intensity. However, further investigations are needed to estimate 
whether ATP depletion is responsible for the changes in cytoskeleton dynamics and 
for triggered γH2Ax response.  
 
6.5 Analysis with ACC and FC 
 
The purpose of analysing the cells with ACC was to gain additional information about 
the phenotype and cell cycle of the cells after each treatment. It was also examined 
whether ACC would be a suitable tool to analyse HCA data in future. The original 
purpose was to identify the cells in interphase and different phases of mitosis to 
examine if some compounds delay specific stage of the cell cycle and estimate 
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whether this might be due to insufficient energy supply. It was noticed that the HCA 
image analysis was not suitable for this since ACC could not distinguish the different 
phases of mitosis from each other even though the number of cells used for training 
of the model should have been adequate. By optimizing the image analysis conducted 
with HCA, it might be possible to accomplish better classification. Also, the number of 
classified cells was quite large and the classification of fewer cells at a time might give 
better results. Despite that the plates with pH3 marker was not used in ACC analysis, 
ACC was able to recognize mitotic cells since the highest percentages of those were 
seen after treatment with paclitaxel and griseofulvin, as expected. Most of the cells, 
despite the compound treatment, appeared to be normal-shaped interphase cells. 
This might suggest that compounds increased the γH2Ax response due to cell cycle 
arrest during interphase.     
 
ACC was also able to recognize the differences between normal, rounded and 
stretched cells. Based on the cell images, MMS and CCCP caused the rounding and 
stretching of the cells and this was also seen in ACC data. The validity of the 
classification was 75.5%, which indicates that almost 25% of the cells were classified 
incorrectly. Hence, the ACC data should be interpreted with caution. However, the 
validity is quite high since the HCA image analysis was not developed or optimized 
specifically for ACC analysis. Thus, even though the image analysis requires 
optimization to reach better validity, it appears that ACC may be a useful tool for 
interpreting HCA data.  
 
FC was used to collect parallel data to compare with HCA data. The purpose was also 
to investigate the similarity of the DNA damage responses seen in these two assays 
and to consider if HCA could be used for genotoxic screening. The FC assay for 
HepG2/C3A cells needs optimizing since the detachment of those cells from the wells 
and from each other varied greatly. This led to the irregular cell count and affected 
the fold of pH3 and γH2Ax and reliable data was not acquired of all of the compounds. 
Thus, it was not possible to conduct a comprehensive comparison between TK6 and 
HepG2/C3A FC data and between HepG2/C3A FC and HCA data. 
 
However, it was observed from the available data that γH2Ax and pH3 responses 
were similar in both assays and cell lines. The changes in responses began on 
average at one concentration lower in TK6 cells than in HepG2/C3A cells. This was 
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probably due to faster proliferation time of TK6 cells. TK6 cells duplicate 1.8 times per 
day whereas HepG2/C3A cells duplicate once. Since the elevation of both γH2Ax and 
pH3 responses were observed similarly in both assays, it is possible that DNA 
damage assays could be conducted by HCA.   
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IV CONCLUSIONS 
 
The aim of the study was to investigate if mitochondrial dysfunction caused by the 
mitochondrial toxins may lead to false positive results in DNA damage assays. The 
purpose was to examine if the ATP depletion caused by the insufficient energy 
production would interfere with the proper functioning of the cell and lead to DNA 
damage responses indirectly. Even though an indirect DNA damage response is an 
actual response, it is not considered as a determining factor of genotoxicity. The focus 
was on investigating if the ATP depletion caused the possible DNA damage via 
changes in cytoskeleton dynamics.  
 
All the examined compounds, excluding metformin, triggered γH2Ax response at least 
at time point 24 h, which indicates that they would induce DNA damage. However, 
when investigating the possible mechanisms of the increased number of γH2Ax 
positive cells, it was observed that nucleus area often correlated negatively with the 
increase. This indicates that the triggered γH2Ax response was a consequence of cell 
death caused by the cytotoxicity. Many of the uncouplers increased the quantity of 
γH2Ax responder cells and nucleus area simultaneously. This may have been an 
indication of a cell cycle arrest after S phase or of some other mechanism than cell 
death that caused the DNA damage. Paclitaxel was the only compound that increased 
the number of pH3 positive cells. Tolcapone and levosimendan seemed to cause 
elevation in pH3 response but the increase was interpreted as an artefact caused by 
the cell count reduction.  
 
Excluding entacapone and metformin, the compounds influenced tubulin and actin. 
The induction of tubulin and actin polymerization seemed to correlate with the 
increase of γH2Ax positive cells. The causality of these two, however, was not 
verified. In case of compounds such as nimesulide and phenformin, there did not 
seem to be an association between changed cytoskeleton dynamics and γH2Ax 
response.  
 
Based on this research the mitochondrial toxins seemed to induce DNA damage but 
probably mostly due to induced cell death and cell cycle arrest in the S-phase. The 
toxins also affected the dynamics of cytoskeleton but the causality of changed 
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dynamics and DNA damage could not be verified. The lack of inducing effect on pH3 
responders indicates that excluding paclitaxel, none of the examined compounds 
induced DNA damage via interference of mitosis. 
 
In the future experiments, some issues should be considered. The DNA damage 
markers, pH3 and γH2Ax should be applied to the same plates to ensure that the 
responses are characteristic to a specific compound. The selection of examined 
compounds could also be more extensive and include cytotoxic compounds that do 
not affect the mitochondria. This would give more information of which responses are 
due to the cytotoxic effect in general and what is caused by the energy deprivation. 
The responses caused by the energy depletion would probably be stronger if the 
conducted research would be repeated with the cells cultivated in galactose medium 
instead of glucose, since glycolysis would not compensate the interference of 
oxidative phosphorylation. Addition of apoptosis marker would also give an 
unambiguous answer whether some responses are caused by the cell death. If the 
concentration series were more frequent, the order of the events might become more 
visible. This might enable the evaluation of possible causality between cytoskeleton 
and γH2Ax. However, to ensure that the top concentration is high enough and the 
lowest concentration low enough, the concentration range needs to be wide. The 
increase in the quantity of concentrations per series might require changing the assay 
from 96-well format to 384-well format. The optimization of the concentration series 
and the top concentration of each compound is important if the HCA assay developed 
in this study would be transferred into screening assay. In screening assay, the 
concentration series need to be fixed.  
 
To conclude, it seems that based on this study the misleading positives in DNA 
damage assays can be caused by mitochondrial toxins and possibly due to energy 
depletion. However, whether this effect was mediated by the changed dynamics of 
tubulin or actin cannot be concluded and requires further investigation. 
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APPENDICES 
 
Appendix A. The results of γH2Ax and pH3 responder analyses of each compound 
treatment at each concentration and at both time points, 6 h and 24 h. The 
responders caused by compound treatment and DMSO are shown on primary y-axis 
and the positive controls on the secondary y-axis. The error bars refer to the 
standard error of the three parallel plates.   
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
Appendix B. The comparison of γH2Ax and pH3 responses with the nucleus area of 
each compounds and controls at both time points, 6 h and 24 h. The responders 
caused by compound treatments and DMSO are shown on primary y-axis and the 
nucleus count on the secondary y-axis. 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
Appendix C. The comparison of γH2Ax and pH3 responses with the tubulin and 
actin intensities of each compounds and controls at both time points, 6 h and 24 h. 
The responders caused by compound treatments and DMSO are shown on primary 
y-axis and the tubulin and actin intensities on the secondary y-axis. 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
